A systematic review of the associations between maternal nutritional biomarkers and depression and/or anxiety during pregnancy and postpartum by Trujillo, Janet et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.jad.2018.02.004
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Trujillo, J., Vieira, M. C., Lepsch, J., Rebelo, F., Poston, L., Pasupathy, D., & Kac, G. (2018). A systematic
review of the associations between maternal nutritional biomarkers and depression and/or anxiety during
pregnancy and postpartum. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.02.004
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
Author’s Accepted Manuscript
A systematic review of the associations between
maternal nutritional biomarkers and depression
and/or anxiety during pregnancy and postpartum
Janet Trujillo, Matias Costa Vieira, Jaqueline
Lepsch, Fernanda Rebelo, Lucilla Poston,
Dharmintra Pasupathy, Gilberto Kac
PII: S0165-0327(17)31816-5
DOI: https://doi.org/10.1016/j.jad.2018.02.004
Reference: JAD9550
To appear in: Journal of Affective Disorders
Received date: 1 October 2017
Revised date: 6 February 2018
Accepted date: 11 February 2018
Cite this article as: Janet Trujillo, Matias Costa Vieira, Jaqueline Lepsch,
Fernanda Rebelo, Lucilla Poston, Dharmintra Pasupathy and Gilberto Kac, A
systematic review of the associations between maternal nutritional biomarkers
and depression and/or anxiety during pregnancy and postpartum, Journal of
Affective Disorders, https://doi.org/10.1016/j.jad.2018.02.004
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com/locate/jad
1 
 
A systematic review of the associations between maternal nutritional biomarkers and 
depression and/or anxiety during pregnancy and postpartum 
Janet Trujillo
1
, Matias Costa Vieira
2
, Jaqueline Lepsch
1
, Fernanda Rebelo
1,3
, Lucilla Poston
2
, 
Dharmintra Pasupathy
21
, Gilberto Kac
11*
 
1
Nutritional Epidemiology Observatory, Department of Social and Applied Nutrition, 
Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Brazil. 
2Division of Women’s Health, Women’s Health Academic Centre, King’s College London, 
Biomedical Research Centre, King’s Health Partners, London, UK. 
3
Clinical Research Service, National Institute of Cancer, Rio de Janeiro, Brazil. 
*Corresponding author: Gilberto Kac, Av. Carlos Chagas Filho, 373 - Bloco J2 - sala 29 
Cidade Universitária, 21941-590 Rio de Janeiro, Brazil, Phone: +552139386595. 
gilberto.kac@gmail.com  
 
Abstract   
Background 
Nutritional requirements need to be met in order to adapt to pre- and postnatal changes. Our 
aim was to systematically review the evidence of associations between nutritional biomarkers 
and psychological distress during pregnancy and in the first postnatal year. 
Methods 
MEDLINE, EMBASE, PsycINFO, Scielo, LILACS, clinicaltrials.gov, International Clinical 
Trials Registry, Cochrane Library, Scopus and Web of Science databases were searched for 
articles from inception to 4/15/2016. Studies of maternal nutritional biomarkers in blood 
(fatty acids/micronutrients/amino acids) and associations with psychological distress 
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(depression/anxiety/stress) were included. Two independent reviewers extracted data based 
on study designs, participants, outcomes, exposures, and association measures. 
Results 
Thirty-eight studies were included. A total of 13 studies showed divergent or no associations 
between serum/plasma/erythrocyte fatty acid concentrations and depression/anxiety during 
pregnancy and postpartum. Changes in serum cholesterol levels from pregnancy to 
postpartum showed a significant inverse correlation with depression in one out of three 
studies. Five out of seven studies found an inverse association between serum vitamin D 
levels and pre- and postnatal depression. Plasma tryptophan levels were inversely correlated 
with postnatal depression scores in three out of four studies. We identified that one out of two 
studies presented no significant association between vitamin B12/folate/ferritin concentrations 
and depression in postpartum.  
Limitations 
There was higher variability between association measures, time and scales of depression and 
anxiety assessments. 
Conclusions 
The majority of high-quality studies suggest that lower vitamin D levels may be associated 
with postpartum depression. However, further evidence is needed for guiding clinical practice 
on nutritional biomarkers.  
 
Key words: nutritional biomarker, postpartum, pregnancy, depression, anxiety, stress  
 
Introduction 
Maternal psychological distress is currently defined as depression, anxiety and stress during 
pregnancy or postpartum. The overall pooled perinatal depression prevalence estimate was 
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11.9% (95% CI 11.4 - 12.5). The prevalence varied depending on whether cases were self-
reported or diagnosed using tools, the time of pregnancy/postpartum, and the income level of 
the country (Woody et al., 2017). The pooled self-reported symptoms and clinical diagnosis 
prevalence for anxiety combined with pregnancy as a whole were 22.9% (95% CI 20.5 - 
25.2) and 15.2% (95% CI 9.0 - 21.4), respectively (Dennis et al., 2017). For postpartum 
anxiety, the pooled prevalence varied from 9.3% (95% CI 5.5 - 13.1) to 17.8% (95% CI 13.9 
- 21.6) and also depended on the time of postpartum and the screening/diagnostic instrument 
used (Dennis et al., 2017). Furthermore, evidence suggests that prenatal depression has 
adverse effects on childhood neurodevelopment and is associated with a higher risk of 
preterm birth and low birth weight (Accortt et al., 2015; Grote et al., 2010). Similar 
associations have been observed between anxiety and these adverse obstetric outcomes (Ding 
et al., 2014). Postnatal depression was found to be associated negatively with cognitive 
development in toddlers and affects the whole family due to its effects on fathers, the 
parenting relationship and children’s health (Kingston et al., 2015; Letourneau et al., 2012).  
Psychological distress in mothers has been related to poor nutrition (Barker et al., 2013; 
Fowles et al., 2011), inadequate prenatal medical care, smoking and alcohol use (Zuckerman 
et al., 1989).  
The development of maternal depression in pregnancy and postpartum has been associated 
with several factors, among them, socioeconomic deprivation, lack of social support, stressful 
life events, domestic violence and preconception and/or pregnancy history of mental health 
problems (Fisher et al., 2012; Lancaster et al., 2010; Patton et al., 2015; Robertson et al., 
2004). It deserves to be mentioned that factors such as hormones (i.e., corticotropin-releasing 
hormone), inflammatory cytokines (i.e., interleukin-6) and genes (i.e., serotonin transporter 
gene) are involved in the risk of the development of postpartum depression (Yim et al., 
2015). Moreover, poor quality and unhealthy diets have also been positively associated with 
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antenatal depressive and stress symptoms (Baskin et al., 2015). In contrast, a healthy diet was 
associated with a decrease in antenatal depression and anxiety symptoms (Baskin et al., 
2015). However, evidence from one systematic review found conflicting associations across 
studies between a healthy diet and postnatal depression symptoms (Baskin et al., 2015). 
Quirk et al. (Quirk et al., 2013) concluded that the evidence of associations between diet 
quality and dietary patterns and the likelihood of depression was still insufficient. Lai et al. 
(Lai et al., 2014) reported that a healthy dietary pattern (characterized by a high intake of 
fruit, vegetables, fish and whole grains) was associated with reduced odds of depression in a 
meta-analysis with high variability among studies (n = 13 studies, OR = 0.84; 95% CI 0.76 - 
0.92; I
2 
= 81.8%, p < 0.001) conducted in a non-pregnant adult population. The evidence 
reported among studies in these reviews (Baskin et al., 2015; Lai et al., 2014; Quirk et al., 
2013) includes differences in sampling characteristics, timing of assessments during 
pregnancy or the postpartum period, and tools used to measure psychological distress and 
dietary quality/dietary intake. Specifically, dietary quality/dietary intake assessments do not 
produce accurate information, and the main reasons for this are related to the following: food-
composition tables, food combinations, and cooking methods.  
Several nutritional changes are required to adapt to the physiological, social and emotional 
alterations that occur during pregnancy and the postpartum period (Baskin et al., 2015; 
Bodnar and Wisner, 2005). These nutritional changes can be assessed using dietary intake 
methods. However, these methods do not provide adequate information for assessment if 
nutritional requirements are being met. In contrast, nutritional biomarkers indicate a more 
precise and integrated measurement of nutrient intake and metabolism (Potischman and 
Freudenheim, 2003).  
These important metabolites play a critical role in mental health physiology by acting in the 
biosynthesis and metabolism of hormones and neurotransmitters of the neurotransmission 
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system, and producing changes in the membranes of neural tissue (Kaplan et al., 2007; Leung 
and Kaplan, 2009; Rechenberg and Humphries, 2013).  
Therefore, it is important to determine the role of maternal nutritional status, assessed by 
biomarkers, in prenatal and postnatal psychological distress, and in that way, avoid the 
possible bias introduced by dietary intake assessments. The aim of this systematic review was 
to evaluate the current evidence regarding the associations between maternal nutritional 
biomarkers and psychological distress during pregnancy and within the first postnatal year.  
 
Methods 
Literature Search 
This systematic review followed the PRISMA and MOOSE guidelines (Moher et al., 2009; 
Stroup et al., 2000). The study protocol was registered in the PROSPERO databases of 
systematic review (www.crd.york.ac.uk; registration number CRD42015018990). We 
performed a comprehensive search of the following electronic databases: Ovid database 
(MEDLINE, EMBASE, PsycINFO), Scielo, LILACS, clinicaltrials.gov, International 
Clinical Trials Registry Platform (WHO), the Cochrane Library, Scopus and Web of Science 
from inception up to the 15
th
 of April of 2016. A combination of Medical Subject Heading 
(MeSH) terms and/or text keywords was used and adapted to each database (the PubMed 
search strategy is presented in Supplementary Table 1). After all records were organized and 
duplicates were excluded, two independent investigators (Dr. JT and MSc JL) screened titles 
and abstracts. The full-text articles were retrieved and screened for inclusion according to the 
eligibility criteria from a list of potential eligible records based on titles and abstracts (see 
below). Moreover, we screened the references lists of the included studies and relevant 
reviews, hand-searched key journals and used forward citation tracking of the included 
studies to identify additional relevant studies. Disagreements on eligibility for inclusion were 
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resolved by discussion until a consensus was reached between the investigators; a third 
reviewer (MSc MCV) was consulted twice. 
 
Selection Criteria 
The PICOS (participants, intervention, comparison, outcome and study design) criteria used 
are presented in Table 1. The included studies were required to meet the following criteria: 
(1) performed in women during pregnancy and/or within the first postnatal year; (2) included 
measurements of maternal nutritional biomarkers, such as fatty acids, micronutrients 
(vitamins and minerals) and amino acids in blood (or its fractions); (3) assessed 
psychological distress, such as depression, anxiety and psychological stress, and diagnosed 
them using symptom questionnaires, screening measures and/or diagnostic assessments; (4) 
included one of the following study designs: prospective cohort, cross-sectional, case-control 
(nested case-control and case-cohort) and baseline of intervention studies; and (5) provided 
statistical and/or epidemiological association measures. Studies were excluded if outcomes 
were assessed only by medication use (such as the use of an antidepressant to diagnose a case 
of depression without a symptom questionnaire, screening measure and/or diagnostic 
assessment) or if the patient had other evaluated mental disorders (e.g., bipolar disorder) or 
physiological stress (not being a psychological evaluation). 
No restrictions were made on publication date. Only studies published in English, Portuguese 
and Spanish were considered for inclusion. 
 
Data Collection 
Two independent investigators (Dr. JT and MSc JL) performed data abstraction using a 
structured form. Any discrepancies were resolved by consensus between the investigators. 
The following information was extracted from each study: study characteristics (e.g., study 
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design, data, country and sample size), participant characteristics (e.g., age, body mass index 
and inclusion/exclusion criteria), assessment of maternal distress (e.g., type of distress and 
assessment), assessment of nutritional biomarkers (e.g., type of biological sample and 
assessment), results (overall frequencies/means of biomarker and mental disorders, measures 
of association, list of adjusting variables) and funding sources. 
Tables were constructed to summarize the data. For studies reporting statistical and 
epidemiological associations, the more complete measure of variability was presented (95% 
confidence interval or p-value). When means and standard deviations were reported stratified 
by groups in the study (such as depressed vs. non-depressed participants for cohort or cross-
sectional studies), they were transformed and reported as a single value describing the total 
sample (Higgins and Green, 2011). 
 
Quality Assessment 
The quality of the studies was assessed by two independent investigators (Drs. JT and FR) 
using the Newcastle-Ottawa Scale (Wells et al., 2012). Any disagreements were discussed 
between the investigators until a consensus was reached. The Newcastle-Ottawa scale 
evaluates the following domains: participant selection, comparability of groups, and 
ascertainment of the outcome or exposure. The scale gives a maximum of one or two points 
on each item depending on the domains, and the maximum total number of points for all 
domains is equal to nine. Studies with total scores from 0-3, 4-6 and 7-9 were considered 
low, moderate and high quality, respectively. Furthermore, for the quality assessment 
graphical representation of each item of each domain, studies were considered of high 
methodological quality if they received the maximum number of points for the item in the 
specific domain and of low quality if they did not. The methodological quality graph 
representation was depicted as a percentage of the number studies with high, moderate and 
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low quality in each item of the specific domain according to the study design (cohort, case-
control and cross-sectional). We used an adapted scale for cross-sectional studies, which 
included the description of statistical tests and appropriateness, sample size, the 
representativeness of the sample, non-respondents, ascertainment of the exposure, 
comparability and assessment of the outcome. Primary research studies that were reported 
more than once were assessed independently due to the different analysis design, outcomes or 
biomarkers and time assessment used. 
 
Results 
Study Selection and Description of Studies 
The search through 10 electronic databases yielded 3,329 records, of which 2,946 were 
screened by title and abstract after excluding duplicates (Figure 1). From this primary 
screening, a total of 124 potential studies were selected for full-text evaluation, of which 38 
met the eligibility criteria for this review (a list of excluded studies and reasons for exclusion 
is available in Supplementary Table 2) (Abou-Saleh et al., 1999; Accortt et al., 2016; Albacar 
et al., 2011; Armony-Sivan et al., 2012; Blunden et al., 2012; Bodnar et al., 2012; 
Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Chong et al., 2015, 2014; Fu et al., 
2015; Grussu et al., 2007; Gur et al., 2014; Hamazaki et al., 2016; Handley et al., 1977, 1980; 
Huang et al., 2014; Maes et al., 1992, 2001; Markhus et al., 2013; Mattes et al., 2009; Otto et 
al., 2003; Parker et al., 2015; Pinto et al., 2016; Ploeckinger et al., 1996; Rees et al., 2009; 
Robinson et al., 2014; Roomruangwong et al., 2016; Sallis et al., 2014; Shiraishi et al., 2015; 
Stein et al., 1976; Teofilo et al., 2014; Troisi et al., 2002; Vaz et al., 2014; van Dam et al., 
1999; Verly-Miguel et al., 2015; Watanabe et al., 2011). Chong et al. (Chong et al., 2015, 
2014); Cassidy-Bushrow et al. (Cassidy-Bushrow et al., 2012), Accortt et al. (Accortt et al., 
2016); Pinto et al. (Pinto et al., 2016), Vaz et al. (Vaz et al., 2014), Verly-Miguel et al. 
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(Verly-Miguel et al., 2015) and Teofilo et al. (Teofilo et al., 2014) reported the same primary 
research, but investigated different associations between biomarkers and psychological 
distress. These studies were also included. 
Table 2 and Table 3 summarize the characteristics and findings of the studies included in this 
review. We then grouped the studies, first according to the principal type of nutritional 
biomarkers, such as micronutrients (vitamins and folate) and amino acids, and second 
according to the time of assessment and type of outcomes (depression, anxiety and stress). 
There were 27 cohort (Accortt et al., 2016; Albacar et al., 2011; Armony-Sivan et al., 2012; 
Blunden et al., 2012; Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 
2012; Chong et al., 2015, 2014; Fu et al., 2015; Gur et al., 2014; Handley et al., 1980, 1977; 
Maes et al., 2001; Markhus et al., 2013; Otto et al., 2003; Parker et al., 2015; Pinto et al., 
2016; Ploeckinger et al., 1996; Robinson et al., 2014; Roomruangwong et al., 2016; Sallis et 
al., 2014; Stein et al., 1976; Teofilo et al., 2014; Troisi et al., 2002; van Dam et al., 1999; 
Wójcik et al., 2006), nine cross-sectional (Abou-Saleh et al., 1999; Grussu et al., 2007; 
Huang et al., 2014; Maes et al., 1992; Mattes et al., 2009; Shiraishi et al., 2015; Vaz et al., 
2014; Verly-Miguel et al., 2015; Watanabe et al., 2010), and 2 case-control (Hamazaki et al., 
2016; Rees et al., 2009) (one nested) studies from the regions of America, Asia, Europe and 
Oceania. The sample sizes varied across the studies, from 18 women in Handley et al. and 
Stein et al. to 4,101 women in the Brandenbarg et al. study (Brandenbarg et al., 2012; 
Handley et al., 1977; Stein et al., 1976). The length of follow-up in the cohort studies varied 
from throughout pregnancy to the 12
th
 postnatal month. 
The nutritional biomarkers were grouped into the following categories: fatty acids, 
cholesterol, micronutrients and amino acids. There were 13 studies for fatty acids (Bodnar et 
al., 2012; Chong et al., 2015; Hamazaki et al., 2016; Markhus et al., 2013; Mattes et al., 
2009; Otto et al., 2003; Parker et al., 2015; Pinto et al., 2016; Rees et al., 2009; Sallis et al., 
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2014; Shiraishi et al., 2015; Vaz et al., 2014; Verly-Miguel et al., 2015). These studies 
reported data on polyunsaturated (PUFA), monounsaturated (MUFA), saturated (SFA) and 
highly unsaturated (HUFA) fatty acids. Fatty acids were measured in red blood cells, plasma 
and serum. Twelve studies were performed during pregnancy, while only one was conducted 
in the postnatal period (Otto et al., 2003). Five studies evaluated cholesterol and HDL 
cholesterol in serum, and of those studies, two studies measured levels during both pregnancy 
and the postnatal period (Grussu et al., 2007; Ploeckinger et al., 1996; Teofilo et al., 2014; 
Troisi et al., 2002; van Dam et al., 1999). 
A total of 21 studies examined micronutrients and amino acids (Abou-Saleh et al., 1999; 
Accortt et al., 2016; Albacar et al., 2011; Armony-Sivan et al., 2012; Blunden et al., 2012; 
Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Chong et al., 
2014; Fu et al., 2015; Gur et al., 2014; Handley et al., 1980, 1977; Huang et al., 2014; Maes 
et al., 2001, 1992; Robinson et al., 2014; Roomruangwong et al., 2016; Stein et al., 1976; 
Watanabe et al., 2010; Wójcik et al., 2006), of which eight examined vitamin D (Accortt et 
al., 2016; Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Fu et 
al., 2015; Gur et al., 2014; Huang et al., 2014; Robinson et al., 2014), two vitamin B12 (Abou-
Saleh et al., 1999; Chong et al., 2014), four folate (Blunden et al., 2012; Bodnar et al., 2012; 
Chong et al., 2014; Watanabe et al., 2010), two zinc (Roomruangwong et al., 2016; Wójcik et 
al., 2006), two ferritin (Albacar et al., 2011; Armony-Sivan et al., 2012), and eight amino 
acids (Abou-Saleh et al., 1999; Bodnar et al., 2012; Handley et al., 1980, 1977, Maes et al., 
2001, 1992; Stein et al., 1976; Watanabe et al., 2010). Vitamin D was measured in serum in 
all of the studies, and only one study assessed levels of vitamin D in the postnatal period (Fu 
et al., 2015). 
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Bodnar et al. (Bodnar et al., 2012) studied several biomarkers simultaneously by estimating 
factor scores for fatty acids, micronutrients and carotenoids through principal components 
analysis. 
Depression was investigated in 35 studies (Abou-Saleh et al., 1999; Accortt et al., 2016; 
Albacar et al., 2011; Armony-Sivan et al., 2012; Blunden et al., 2012; Bodnar et al., 2012; 
Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Chong et al., 2015, 2015; Fu et al., 
2015; Grussu et al., 2007; Gur et al., 2014; Handley et al., 1980, 1977; Huang et al., 2014; 
Maes et al., 1992; Markhus et al., 2013; Mattes et al., 2009; Otto et al., 2003; Parker et al., 
2015; Pinto et al., 2016; Ploeckinger et al., 1996; Rees et al., 2009; Robinson et al., 2014; 
Roomruangwong et al., 2016; Sallis et al., 2014; Shiraishi et al., 2015; Stein et al., 1976; 
Teofilo et al., 2014; Troisi et al., 2002; van Dam et al., 1999; Vaz et al., 2014; Watanabe et 
al., 2010; Wójcik et al., 2006), anxiety in seven (Chong et al., 2015; Huang et al., 2014; Maes 
et al., 2001, 1992; Roomruangwong et al., 2016; Troisi et al., 2002; Verly-Miguel et al., 
2015), stress in one (Huang et al., 2014), and psychological distress as a composite 
assessment in a single study (Hamazaki et al., 2016).  
There were five studies that assessed depression and anxiety at the same time in pregnancy 
and postpartum (Chong et al., 2015; Huang et al., 2014; Maes et al., 1992; Roomruangwong 
et al., 2016; Troisi et al., 2002). However, those studies did not report data on the associations 
of comorbidity. Two other studies reported data on the associations between nutritional 
biomarkers and depression through an analysis adjusted by anxiety (Roomruangwong et al., 
2016; Teofilo et al., 2014).  
Depression frequencies varied from 5.8% to 61.6%, depending on the assessment tool, the 
cut-off point of the scale used, the assessment period and population. The Edinburgh 
Postnatal Depression Scale (EPDS) was the most commonly used scale for assessing 
depression (in 19 of 35 studies), but each study used different cut-off points (range: 8 to 15) 
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and applied the scale to both antenatal and postnatal assessment. The Spielberger’s State-
Trait Anxiety Index (STAI) was the most commonly used scale to assess anxiety in both 
antenatal and postnatal periods (in 5 of 7 studies) (Chong et al., 2015; Maes et al., 2001, 
1992; Roomruangwong et al., 2016; Troisi et al., 2002). Stress was assessed through the 
Depression, Anxiety and Stress Scales 21-item short form (DASS-21) (Huang et al., 2014). 
The data were reported separately for each of the subscales (Huang et al., 2014). The 
assessment of psychological distress, as a whole was evaluated by the Kessler Psychological 
Distress Scale (Hamazaki et al., 2016).  
 
Methodological Quality 
The studies’ NOS scores are presented in Table 2 and the summary by item of each domain 
of the NOS is shown in Figure 2. We found only two out of 38 studies of low quality (NOS 
scores < 4), and those studies referred to tryptophan and cholesterol (Ploeckinger et al., 1996; 
Stein et al., 1976). For fatty acids, 77% (10 from 13) were studies of high quality (Bodnar et 
al., 2012; Chong et al., 2015; Hamazaki et al., 2016; Markhus et al., 2013; Mattes et al., 
2009; Parker et al., 2015; Pinto et al., 2016; Rees et al., 2009; Vaz et al., 2014; Verly-Miguel 
et al., 2015) (NOS scores  7). For cholesterol, there were two studies of high quality 
(Teofilo et al., 2014; van Dam et al., 1999) and two of moderate quality (Grussu et al., 2007; 
Troisi et al., 2002). Most studies of vitamin D were of high quality (7 of 8 studies) (Accortt et 
al., 2016; Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Fu et 
al., 2015; Huang et al., 2014; Robinson et al., 2014). The majority of studies of vitamin B12 
and folate were of moderate quality (3 of 5 studies) (Abou-Saleh et al., 1999; Blunden et al., 
2012; Bodnar et al., 2012; Chong et al., 2014; Watanabe et al., 2010). 
Studies of ferritin and zinc were all of moderate quality (Albacar et al., 2011; Armony-Sivan 
et al., 2012; Roomruangwong et al., 2016; Wójcik et al., 2006). 
13 
 
Four cohort studies reported the exclusion of women with the outcomes at the start of the 
study when the quality of studies was analyzed according to each domain item (Chong et al., 
2015, 2014; Gur et al., 2014; van Dam et al., 1999). Twelve cohort studies adjusted for 
confounding factors in the design and/or data analysis (Accortt et al., 2016; Bodnar et al., 
2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012; Chong et al., 2015, 2014; Fu 
et al., 2015; Otto et al., 2003; Robinson et al., 2014; Sallis et al., 2014; Teofilo et al., 2014; 
van Dam et al., 1999). No cross-sectional study provided information on the sample size and 
comparability between respondents and non-respondents (Abou-Saleh et al., 1999; Grussu et 
al., 2007; Huang et al., 2014; Maes et al., 1992; Mattes et al., 2009; Shiraishi et al., 2015; Vaz 
et al., 2014; Verly-Miguel et al., 2015; Watanabe et al., 2010). Case-control studies provided 
adequate information for most of the items (Hamazaki et al., 2016; Rees et al., 2009). 
 
Main Findings 
The included studies reported findings obtained with a variety of different measures of 
association and over a time span from pregnancy to the postnatal period (Tables 2 and 3). A 
summary of the associations between biomarkers and depression in women during pregnancy 
and the first postpartum year reported in at least two included studies is shown in Table 4.  
 
FATTY ACIDS 
Associations between fatty acids and depression were evaluated in total of 11 studies, those 
between fatty acids and anxiety were evaluated in two studies, and those between fatty acids 
and psychological distress were evaluated in one study.  
Depression in Pregnancy 
There were seven studies reporting data on fatty acids and their relation to depression in 
pregnancy. 
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Three studies found that ω-3 PUFA levels were not significantly associated with depression 
during pregnancy (Chong et al., 2015; Mattes et al., 2009; Rees et al., 2009). A longitudinal 
analysis showed that higher serum ω-3 PUFA levels were associated with a lower probability 
of developing depression during pregnancy (n = 172, OR = 0.98, 95% CI = 0.96 - 0.99) 
(Pinto et al., 2016). 
Total ω-6 PUFAs were found to be a risk factor for depression during pregnancy, but this 
association was not statistically significant (Chong et al., 2015; Mattes et al., 2009; Pinto et 
al., 2016; Rees et al., 2009). One study examined the associations between serum levels of 
total ω-3, ω-6 HUFA and total MUFA and major depressive episodes in the first trimester, 
finding a non-significant association between them (n = 194) (Vaz et al., 2014). 
There were conflicting results for the associations of docosahexaenoic acid (DHA), 
eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and fatty acid ratios (such as ω-
6/ω-3) with depression across the studies, even if an adjusted analysis was applied (Chong et 
al., 2015; Markhus et al., 2013; Mattes et al., 2009; Otto et al., 2003; Parker et al., 2015; 
Pinto et al., 2016; Rees et al., 2009). 
Depression in Postpartum 
There were three studies assessing fatty acids and depression in postpartum.  
Parker et al. (Parker et al., 2015) found that lower levels of red blood cell total ω-3 and higher 
levels of red blood cell ω-6 PUFA were associated with a higher probability of depression 
(EPDS ≥ 10) (n = 895, adjusted ORs = 1.1, p < 0.05 for both). 
Levels of red blood cell total SFA and total MUFAs were inversely and non-significantly 
correlated with EPDS scores in the third postnatal month (Markhus et al., 2013; Parker et al., 
2015). 
The postnatal change between the periods after delivery and the 32
nd 
postnatal week in 
plasma DHA/ω-6 DPA ratio showed that a 1-unit increase produced a decrease in the 
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probability of depression (EPDS ≥ 10) (n = 112, adjusted OR = 0.88, p = 0.03) (Otto et al., 
2003). 
Anxiety and Psychological Distress 
Serum DHA levels were significantly associated with anxiety in the first trimester (n = 228, 
adjusted ORs = 1.95, 95% CI = 1.00 - 3.77, p = 0.047), but serum ω-6 and ω-3 PUFA levels 
were not significantly associated with anxiety (Verly-Miguel et al., 2015). In the third 
trimester, there were significant positive associations between plasma ω-6/ ω-3, AA/DHA, 
and AA/EPA levels and anxiety; additionally, there were negative associations between total 
ω-3 PUFA levels and anxiety (n = 698) (Chong et al., 2015). None of these plasma fatty acids 
were shown to be significantly associated with anxiety three months postpartum (p < 0.05) 
(Chong et al., 2015).  
High serum EPA levels were associated with a low risk of having psychological distress 
(Kessler scale scores ≥ 9) in early pregnancy (n = 283, adjusted OR = 0.47, 95% CI = 0.30 - 
0.73) (Hamazaki et al., 2016). 
 
CHOLESTEROL 
A total of 5 studies evaluated the association between cholesterol and depression (HDL-
cholesterol in two of them) (Grussu et al., 2007; Ploeckinger et al., 1996; Teofilo et al., 2014; 
Troisi et al., 2002; van Dam et al., 1999), and one examined the association between 
cholesterol and anxiety (Troisi et al., 2002). 
Depression in Pregnancy 
There were two studies assessing depression in pregnancy and HDL-cholesterol levels 
(Teofilo et al., 2014; Troisi et al., 2002) and one study examining depression and total 
cholesterol (Troisi et al., 2002). One out of two studies reported a significant inverse 
association between a 1-unit increase of HDL-cholesterol and longitudinal EPDS score 
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changes during pregnancy (n = 238) (Teofilo et al., 2014), while the other study did not (n = 
47) (Troisi et al., 2002).  
Depression in Postpartum 
There were four studies reporting data on depression and cholesterol in postpartum (Grussu et 
al., 2007; Ploeckinger et al., 1996; Troisi et al., 2002; van Dam et al., 1999). Three studies 
assessed the association between depression and cholesterol changes from pregnancy to 
postpartum (Ploeckinger et al., 1996; Troisi et al., 2002; van Dam et al., 1999). One out of 
three studies found a significant inverse correlation between depression, as measured by 
Zung scores, and cholesterol changes, with an exception for the 4
th
 day of assessment (n = 
20). The other two studies did not report significant associations (sample sizes varied from 47 
to 405) (Troisi et al., 2002; van Dam et al., 1999). 
Two studies showed a significant inverse association between depression and cholesterol in 
early postpartum (Grussu et al., 2007; Troisi et al., 2002).  
Anxiety 
Cholesterol was found to be inversely but non-significantly correlated with STAI scores in 
the antenatal and postpartum periods, while serum HDL-cholesterol was significantly 
associated with anxiety in the postnatal period (n = 47, r = -0.34, p = 0.02) (Troisi et al., 
2002). 
 
MICRONUTRIENTS and AMINO ACIDS 
Micronutrients and amino acids were investigated in 20 studies investigating depression 
(Abou-Saleh et al., 1999; Accortt et al., 2016; Albacar et al., 2011; Armony-Sivan et al., 
2012; Blunden et al., 2012; Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow 
et al., 2012; Chong et al., 2014; Fu et al., 2015; Gur et al., 2014; Handley et al., 1980, 1977; 
Huang et al., 2014; Maes et al., 1992; Robinson et al., 2014; Roomruangwong et al., 2016; 
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Stein et al., 1976; Watanabe et al., 2010; Wójcik et al., 2006), and three studies in relation to 
anxiety (Huang et al., 2014; Maes et al., 2001, 1992; Roomruangwong et al., 2016). 
 
Vitamin D 
There were eight studies examining the relationship between vitamin D and depression 
(Accortt et al., 2016; Bodnar et al., 2012; Brandenbarg et al., 2012; Cassidy-Bushrow et al., 
2012; Fu et al., 2015; Gur et al., 2014; Huang et al., 2014; Robinson et al., 2014). One of 
these studies also examined anxiety and stress (Huang et al., 2014).  
Depression in Pregnancy 
A total of three studies reported on vitamin D and depression in pregnancy (Brandenbarg et 
al., 2012; Cassidy-Bushrow et al., 2012; Huang et al., 2014), of which two found significant 
associations (Brandenbarg et al., 2012; Cassidy-Bushrow et al., 2012). Brandenbarg et al. 
(Brandenbarg et al., 2012) found that serum vitamin D deficiency (≤ 29.9 nM) and 
insufficiency (30-49.9 nM) were significantly associated with an increased likelihood of 
depression, as indicated by scores of ≥ 16 on the Center for Epidemiological Studies 
Depression Scale (CESD) during pregnancy in the adjusted analysis (major cohort between 
the included studies, n = 4.101) (adjusted ORs (95% CI): 1.48 (1.13 - 1.95) and 1.44 (1.12 - 
1.85) for vitamin D deficiency and insufficiency, respectively) (Huang et al., 2014). The 
other study found that a 1-unit increase of log serum vitamin D levels was significantly 
associated with a 46% decreased likelihood of depression (CESD ≥ 16) (n = 178, p = 0.046) 
in the adjusted analysis (Cassidy-Bushrow et al., 2012). 
Depression in Postpartum 
A total of four studies evaluated depression and vitamin D in postpartum (Accortt et al., 
2016; Fu et al., 2015; Gur et al., 2014; Robinson et al., 2014). Three of the four studies (75%) 
showed a significant inverse association between serum vitamin D levels and depression 
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scores, which were evaluated by the EDPS in the early and/or late postnatal time frame 
(sample sizes varying from 208 to 929) (Fu et al., 2015; Gur et al., 2014; Robinson et al., 
2014). The remaining study did not show this association (Accortt et al., 2016) (n = 91). 
However, Accortt et al. (Accortt et al., 2016) showed that higher levels of pro-inflammatory 
cytokines, such as interleukin-6 and the interleukin-6/interleukin-10 ratio, significantly 
moderate the association between lower prenatal vitamin D levels and higher postpartum 
depression symptoms.  
Anxiety and Stress 
Only one out of eight (12.5%) studies of vitamin D investigated the association with anxiety 
and stress in pregnancy (Huang et al., 2014). Huang et al. (Huang et al., 2014) investigated 
anxiety and stress by using the Depression, Anxiety and Stress Scales (DASS) in a cross-
sectional study of pregnant women, and the results showed a non-significant positive 
association between serum vitamin D levels and both scales scores (n = 498, adjusted linear 
coefficients: 0.019 (p = 0.398) and 0.037 (p = 0.281), respectively). 
 
Vitamin B12 and Folate 
There were three studies on the association between depression and folate (Blunden et al., 
2012; Chong et al., 2014; Watanabe et al., 2010) and two studies on the association between 
depression and vitamin B12 (Abou-Saleh et al., 1999; Chong et al., 2014). There is no study 
assessing the association between anxiety and vitamin B12 and folate. Three studies reported 
that pregnant women used folate and vitamin B12 supplements (Blunden et al., 2012; Chong 
et al., 2014; Watanabe et al., 2011). 
Depression in Pregnancy 
Only one study evaluated vitamin B12 levels and depression during the prenatal period and 
found a non-significant association between them (n = 967, adjusted OR = 1.07, 95% CI = 
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0.79 - 1.45, p = 0.672) (Chong et al., 2014). One study of folate reported a significant 
association with depression, as measured by the EPDS, in the 26
th
-28
th
 gestational week (n = 
967, adjusted OR = 0.69, 95% CI = 0.52 - 0.94) (Chong et al., 2014), while the another study 
(50%) did not. In this later study, depression was evaluated by the CESD in the 6
th
-11
th
 
gestational week (n = 86) (Watanabe et al., 2010). 
Depression in Postpartum 
There were two studies evaluating the association between depression and vitamin B12 
(Abou-Saleh et al., 1999; Chong et al., 2014) and two studies evaluating the association 
between depression and folate (Blunden et al., 2012; Chong et al., 2014) in postpartum. 
For vitamin B12, one study (50%) found a significant positive correlation with EPDS scores 
(n = 62) (Abou-Saleh et al., 1999). Meanwhile, the other study (50%) reported no significant 
association (n = 967, adjusted OR  = 1.08, 95% CI = 0.83 - 1.40) (Chong et al., 2014). 
One out of two studies of folate (50%) identified a significant association with depression 
evaluated in the third postpartum month (n = 967) (Chong et al., 2014), while the other study, 
which assessed depression in the 6
th
-12
th
 postpartum month (n = 2,856), did not find a 
significant association (Blunden et al., 2012).  
 
Amino Acids 
A total of seven studies reported data on the association between amino acids and depression 
(Abou-Saleh et al., 1999; Handley et al., 1980, 1977; Maes et al., 1992; Stein et al., 1976; 
Watanabe et al., 2010), and two studies investigated the association between amino acids and 
anxiety (Maes et al., 2001, 1992). 
Depression in Pregnancy 
Only one study assessed homocysteine and depression in pregnancy and found no association 
between them (n = 86, adjusted OR = 0.63, 95% CI = 0.23-1.72) (Watanabe et al., 2010).  
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Depression in Postpartum 
There were a total of five studies assessing the relation between the amino acids and 
depression (Abou-Saleh et al., 1999; Handley et al., 1980, 1977; Maes et al., 1992; Stein et 
al., 1976). Three studies (75%) found a significant inverse correlation between tryptophan 
and depression (sample sizes varied from 18 to 62) (Abou-Saleh et al., 1999; Handley et al., 
1977; Stein et al., 1976), and one study (25%) did not (n = 71) (Handley et al., 1980).  
Furthermore, one study evaluated the ratio of plasma tryptophan and the sum of the levels of 
valine, leucine, isoleucine and phenylalanine and found a significant inverse correlation with 
depression (n = 29, r = -0.46, p = 0.007), as measured by Zung scores (Maes et al., 1992). 
Anxiety 
The ratio of plasma tryptophan and the sum of the levels of valine, leucine, isoleucine and 
phenylalanine was significantly inversely correlated with anxiety, as measured by Zung 
scores and STAI scores (n = 29) (Maes et al., 1992). Another study reported that changes in 
plasma phenylalanine were significantly correlated with changes in STAI scores from the 3
rd
-
6
th
 day before delivery to the 1
st
 and 3
rd
 postnatal day (n = 98, r = 0.16, p = 0.04) (Maes et al., 
2001). 
 
Ferritin 
A total of two studies reported data on the association between ferritin and depression 
(Albacar et al., 2011; Armony-Sivan et al., 2012), and no study assessed the relationship 
between ferritin and anxiety.  
Depression in Postpartum 
One study reported a significant association between lower levels of serum ferritin (< 7.26 
μg/L) and a higher risk of depression (scored by the EPDS as > 9) at 8-32 weeks postnatally 
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(n = 729, OR = 3.73; 95% CI = 1.84-7.56) (Albacar et al., 2011), while the other study did 
not find this association (n = 567) (Armony-Sivan et al., 2012).  
 
Zinc 
A total of two studies investigated the relation between zinc and depression 
(Roomruangwong et al., 2016; Wójcik et al., 2006), and one study examined the association 
between zinc and  anxiety (Roomruangwong et al., 2016).  
Depression in Pregnancy and Postpartum 
One out of two studies reported an OR (95% CI) of 4.16 (1.42 - 12.22) of having depression, 
scored as 11 on the EPDS, in the third trimester with a 1-unit increase of the inverse of 
serum zinc levels (Roomruangwong et al., 2016). 
Two studies (Roomruangwong et al., 2016; Wójcik et al., 2006) found that serum zinc levels 
were significantly inversely correlated with depression symptoms. One of these studies 
assessed depression in the third trimester and in the 4
th
-6
th
 postpartum week 
(Roomruangwong et al., 2016), and the other study assessed depression in the 3
rd
 and 30
th
 
postpartum day (Wójcik et al., 2006) (sample sizes of studies less than 75).  
Anxiety 
Roomruangwong et al. (Roomruangwong et al., 2016) found a non-significant inverse 
correlation between zinc levels and STAI scores in the third trimester and in the 4
th
-6
th
 
postpartum week (n = 72, r = -0.042, p = 0.729). 
 
PATTERNS of FATTY ACIDS, CAROTENOIDS and MICRONUTRIENTS  
Bodnar et al. (Bodnar et al., 2012) found that the highest tertiles of essential fatty acids and 
carotenoid scores were associated with a decreased risk of major depressive disorder during 
pregnancy. The highest tertile of micronutrient scores showed a decrease in the risk of a 
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major depressive disorder. All of the associations were non-significant after adjusting for 
several confounders.  
 
Discussion 
The current review summarizes the evidence of associations between a broad number of 
nutritional biomarkers and psychological distress. The variability across the studies with 
respect to timing of psychological assessments, the scales employed for diagnosis/screening 
and the measures of association did not allow for a formal pooled analysis. Furthermore, our 
review found conflicting results for most of the relationships studied. Fatty acids were the 
most frequently studied biomarker, but studies showed divergent or non-significant 
associations. Most studies assessing serum vitamin D presented a significant inverse 
association with depression during pregnancy and in the postnatal period. The same trend was 
observed between plasma tryptophan levels and postnatal depression. Anxiety and stress were 
under-investigated in relation to nutritional biomarkers. 
Studies identified psychological distress using clinical and self-reported interviews. Several 
different tools were used to assess depression, and even if studies applied the same scale, the 
diagnostic/screening cut-off point or the assessment time point for each biomarker varied 
between the studies. Additionally, for the comparison of results between the studies, it is 
important to consider that depression cases could have been mild to moderate and in a 
heterogeneous clinical population (based on the inclusion/exclusion criteria and sample 
characteristics for each study). Furthermore, studies assessing depression less than one week 
after delivery could be confounded by the “baby blues” or postpartum blues, even if 
depression was evaluated as a continuous score. Therefore, all these issues, together with the 
biomarkers limitations, could have attenuated or weakened the power to find associations or 
comparisons across the studies.  
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Associations between nutritional biomarkers and depression/anxiety could have been due to 
chance as a result of the small study sample sizes. Studies with small sample size are 
underpowered to detect significant associations. In our review, 14 out of 38 (37%) studies 
presented sample sizes smaller than 100 women (Abou-Saleh et al., 1999; Accortt et al., 
2016; Handley et al., 1977, 1980, Maes et al., 1992, 2001; Markhus et al., 2013; Ploeckinger 
et al., 1996; Rees et al., 2009; Roomruangwong et al., 2016; Stein et al., 1976; Troisi et al., 
2002; Watanabe et al., 2010; Wójcik et al., 2006). As a consequence of the small sample 
sizes, their findings need to be considered with caution. However, when the sample size is 
larger, there is the possibility of finding a significant association, especially when the 
association is small, because the sample better represents the population from which it is 
derived. 
Furthermore, a total of 15 studies assessing correlations did not perform an adjusted analysis 
for potential confounders. Studies with adjusted analyses used at least one of the maternal 
confounders, such as age/parity/marital status, or a comprehensive list. 
We did not find any study that assessed the comorbidity of depression and anxiety during 
pregnancy and postpartum and its association with nutritional biomarkers. However, there 
were studies evaluating both of them separately or in the adjusted analysis. The presence of 
comorbidity in the studies, which was not assessed, could have overestimated the strength of 
association (being positive or negative) between each outcome and a certain nutritional 
biomarker.  
Some studies reported the use of supplementation independently when the biomarker was 
measured. This fact could potentiate or interfere with the development of depression (Accortt 
et al., 2016; Blunden et al., 2012; Cassidy-Bushrow et al., 2012; Chong et al., 2015, 2014; 
Gur et al., 2014; Markhus et al., 2013), especially in postnatal depression, for which there 
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was insufficient evidence addressing dietary supplementation (selenium, DHA or EPA or 
other supplement) as a preventative measure (Miller et al., 2013). 
Essential and non-essential fatty acids were investigated in relation to psychological distress. 
They were measured in different blood fractions. It is of note that erythrocytes reflect the 
long term intake of ω-3 PUFA and trans fatty acids among the other fractions, with less 
biological variability for EPA and DHA and a half-life of 120 days, and is superior to plasma 
lipoproteins (Harris and Thomas, 2010; Sun et al., 2007). Therefore, studies that measured 
fatty acids in erythrocytes showed relationships with depression characterized by less 
variability and sensitivity to recent intake than studies using other fractions (Bodnar et al., 
2012; Markhus et al., 2013; Mattes et al., 2009; Parker et al., 2015; Sallis et al., 2014). 
Additionally, it is important to note that studies reported fatty acids as absolute amounts 
(Chong et al., 2015; Pinto et al., 2016; Shiraishi et al., 2015; Verly-Miguel et al., 2015), or 
percentages of total fatty acids (Bodnar et al., 2012; Hamazaki et al., 2016; Markhus et al., 
2013; Mattes et al., 2009; Otto et al., 2003; Parker et al., 2015; Rees et al., 2009; Sallis et al., 
2014; Vaz et al., 2014). These two reporting approaches of fatty acids can lead to different 
association results across studies, because when fatty acids are expressed as a weight 
percentage, each one is affected by changes in the other measured fatty acids. In the case of 
absolute amount, the results are independent for each fatty acid measured (Mocking et al., 
2012; Schwertner and Mosser, 1993; Sergeant et al., 2016). 
It is worth noting that the lack of evidence of a robust association between red blood cell 
DHA and EPA and perinatal-onset, prenatal and postnatal depression is based on an approach 
free of confounding and reverse causality (Sallis et al., 2014). There are problems in some 
observational studies included in our systematic review. Therefore, the associations found in 
those studies may not be actual associations. More studies in different settings free of 
confounding and reverse causality are necessary to confirm this finding. 
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The findings of Teofilo et al. (Teofilo et al., 2014) regarding depression and serum HDL 
cholesterol should be considered with caution, as the authors have included a subsample of 
women with supplementation of 1.08 g EPA + 0.72 g DHA per day. However, there is 
evidence showing that DHA and EPA supplementation does not have a beneficial effect on 
perinatal depression symptoms (Jans et al., 2010). It is important to consider the possible 
effect of DHA+EPA supplementation on HDL-cholesterol levels (Jacobson et al., 2012; Wei 
and Jacobson, 2011), and in this case, on our diverse results for the associations with DHA 
and EPA, which could have introduced bias into the findings.  
Evidence from adult women showed a positive relationship between high HDL cholesterol 
levels and higher depression scores, the standardized mean difference being 0.20 (95% CI 
0.07 - 0.34; p < 0.01; Q = 2.10; pooled data from four studies). For total cholesterol, the 
relationship was inverse, with a standardized mean difference of -0.23 (95% CI -0.37- -0.10; 
p < 0.01; Q = 18.64, data pooled from 12 studies) (Shin et al., 2008). 
The findings of Accortt et al. (Accortt et al., 2016) should be interpreted with caution because 
women received vitamin D supplements. Thus, this supplementation could have attenuated 
the development of postnatal depression from the first trimester to the first postnatal month, 
despite the fact that the interaction with pro-inflammatory cytokines remained significant. 
Several factors can influence vitamin D levels, such as the season of vitamin D measurements 
given different to the exposures to sun-light, ethnicity and vitamin D supplementation. 
However, not all of the studies reported data on these factors or the percentages of women 
with deficient or insufficient levels. A recent review investigated vitamin D levels measured 
during pregnancy and their association with postpartum depression, the results of which 
suggested a correlation (Mahmood et al., 2015). Three studies were included, one of which 
classified depression by antidepressant use (Nielsen et al., 2013). However, the use of 
antidepressants was an exclusion criterion in our review.  
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In addition, the effect of vitamin D on depression was investigated through a systematic 
review with meta-analysis in the adult population. For cohort studies, there was a significant 
increase in the hazard ratio of depression for the lowest versus the highest serum vitamin D 
categories (vitamin D deficiency and normal levels defined by each study) (pooled HR = 
2.21, 95% CI = 1.40 - 3.49, p < 0.001, I
2 
= 21%, n = 3 studies and 8,815 participants). In the 
case of cross-sectional studies, the pooled OR was 1.31 (95% CI = 1.0 - 1.75, p = 0.05, I
2 
= 
54%, n = 9 studies and 22,318 participants) for depression for the lowest versus the highest 
vitamin D categories (Anglin et al., 2013). Nevertheless, it is well known that women are 
under different physiological, social, physical and emotional situations during pregnancy and 
postpartum.  
Folate and iron are recommended as daily supplements as early as possible in pregnancy 
because they reduce the risk of negative maternal and neonatal outcomes (WHO, 2012). 
However, for antenatal/postnatal depression, there is still inconsistent evidence in our review 
to support an association with folate levels. 
Some studies selected samples based on ethnicity criteria (Accortt et al., 2016; Albacar et al., 
2011; Cassidy-Bushrow et al., 2012; Chong et al., 2015, 2014; Fu et al., 2015; Robinson et 
al., 2014; Sallis et al., 2014; van Dam et al., 1999), while other studies performed analyses 
adjusted by ethnicity (Brandenbarg et al., 2012; Chong et al., 2015, 2014; Huang et al., 
2014), or only reported these data (Bodnar et al., 2012; Vaz et al., 2014). However, the 
studied samples are from numerous countries (in America, Asia, Europe and Oceania), which 
indicated some important general characteristics, such as sun-light exposure, dietary habits, 
and income status of the country (which is also associated with the depression/anxiety 
prevalence rate, as previously mentioned). For the studies with samples restricted to specific 
ethnicities, the results should be considered with caution, as they are not generalizable to the 
overall population.  
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Maternal nutritional biomarkers are the biological results of dietary intake through different 
metabolic/biochemical processes. At the same time, these biomarkers play roles in metabolic 
pathways; some of them link to neural processes. The possible biological plausibility of 
biomarkers on depression are as follows: a) vitamin D acts in neurotransmitter synthesis and 
calcium homeostasis (Garcion et al., 2002; McCann and Ames, 2008); b) vitamin B12 is 
linked to the efficient functioning of the folate cycle, which is necessary for the synthesis and 
regeneration of tetrahydrobiopterin, an essential cofactor for the conversion of amino acids to 
neurotransmitters (serotonin, melatonin, dopamine, noradrenaline, adrenaline) (Bottiglieri, 
2005; Kennedy, 2016); c) tryptophan acts in the synthesis of serotonin, melatonin and 
kinurenines (Fernstrom, 2013); and d) fatty acids and cholesterol affect membrane structures, 
neurotransmitter uptake and signal transmission (Bodnar and Wisner, 2005; Scanlon et al., 
2001).  
The bioavailability of these nutritional biomarkers in the body is mostly dependent upon the 
quality of dietary intake, which could be influenced by psychosocial factors during pregnancy 
and during the postpartum period (George et al., 2005; Fowles et al., 2011; Hurley et al., 
2005). In pregnant women, psychosocial distress is related to worse dietary quality (Fowles et 
al., 2011). Therefore, psychosocial factors should also be considered in women during 
pregnancy and the postpartum period when attending routine care to avoid potential adverse 
outcomes.  
Strengths, Limitations and Future Directions 
Our study has several strengths, such as the broad number of nutritional biomarkers 
examined; the extensive literature search of terms and the number of databases included; and 
the hand-searching, and forward citation tracking and assessment of studies’ methodological 
quality. However, we cannot reject the possibility of publication bias. 
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Some limitations of our current review need to be highlighted. First, we cannot combine the 
data from the studies due to the higher variability of association measures given as 
correlations, odds ratios, longitudinal or linear or logistic regression coefficients, relative risk 
and their 95% confidence intervals or p-values. Studies that assessed the same biomarkers or 
anxiety or stress and the outcomes and/or exposure expressed as continuous or categorical 
variables were few in number. Another limitation was only including studies that provided 
data on association measures. Studies that did not report the magnitude of associations were 
not included in our review.  
Finally, we note some possible future directions that emerged from this systematic review 
(Table 5). Briefly, there is a lack of data on nutritional biomarkers and anxiety and 
psychological stress. Additional well-designed epidemiological studies are needed, as well as 
reports of the ethnicity of studied sample and other important confounders. Depression during 
pregnancy and postpartum should be assessed by a single standard tool through the studies, 
i.e.. the EPDS or a diagnostic interview. Fatty acid levels should be presented in absolute 
concentrations. Nutritional supplementation, women’s nutritional status, trace elements, 
amino acids, vitamins, lipids and psychological distress should be assessed throughout both 
pregnancy and postpartum in prospective studies. 
 
Conclusions 
This systematic review summarized the current evidence of a broad number of nutritional 
biomarkers and depression/anxiety during pregnancy and postpartum. Pregnant women with 
lower vitamin D levels had an increased probability of depression during pregnancy and in 
the postnatal period. To reinforce this finding, Vaziri et al. (2016) reported that consuming 
2000 IU of vitamin D daily from the 26
th
-28
th
 gestational week until childbirth significantly 
reduced the EPDS scores assessed in the 38
th
-40
th
 gestational week and the fourth and eighth 
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week after birth (n = 169, randomized clinical trial, p < 0.001, women with scores of EPDS 
>13 were excluded) (Vaziri et al., 2016). There are a small number of studies evaluating 
anxiety and stress in comparison to depression. For fatty acids, studies were so diverse that 
we suggest that new evidence providing levels of nutritional biomarkers as absolute 
concentrations and reporting measures of the risk of adverse outcomes more consistently are 
needed. Micronutrients were under investigated; therefore, additional longitudinal studies are 
necessary, particularly those examining vitamin A and minerals involved in neurotransmitter 
function. Women’s nutritional status should be reported in studies of micronutrients. In 
summary, further evidence is necessary for guiding clinical practice in the relationships of 
nutritional biomarkers and depression/anxiety during pregnancy and postpartum.  
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Figure 1. Flowchart of study selection according to the PRISMA guideline. 
Figure 2. Methodological quality assessed by the Newcastle-Ottawa scale. Studies were 
considered as being high methodological quality if they received the maximum number of 
points for the item in the specific domain and low quality if they did not. Methodological 
quality is presented as a percentage of number of studies with high, moderate and low quality 
in each item of the specific domain by epidemiological design. High = high methodological 
quality, Moderate = moderate methodological quality, Low = low methodological quality. A) 
Cohort studies; B) cross-sectional studies; C) case-control studies.  
Table 1. PICOS criteria for inclusion and exclusion of studies. 
Parameter Inclusion criteria Exclusion criteria 
Participants 
Women during pregnancy and/or at the first 
year of postpartum period. 
 
Intervention 
Maternal nutritional biomarkers (such as fatty 
acids, vitamins, minerals and amino acids) 
measured in blood. 
 
Comparators None specified  
Outcomes 
Psychological distress (depression, anxiety and 
psychological stress) diagnosed using symptom 
questionnaires, screening measures and/or 
diagnostic assessments. 
Outcomes assessed only by 
medication use (such as 
antidepressant to diagnose 
a case of depression 
without a symptom 
questionnaire, screening 
measure and/or diagnostic 
assessment) or if the 
patient had other evaluated 
mental disorders (e.g. 
bipolar disorder) or 
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physiological stress (not 
being a psychological 
evaluation). 
 
Study 
design 
Prospective cohort, cross-sectional, case-control 
designs (nested case-control and case-cohort) 
and intervention studies (only baseline data). 
 
 
Table 2. Characteristics of included studies evaluating the associations between fatty acids 
and cholesterol and psychological distress in women during pregnancy and the first 
postpartum year. 
Study, country 
Study 
design, 
sample 
size and 
age 
(mean ± 
SD) 
Psychological 
distress (%, 
assessment tool, 
timing) 
Nutritional 
biomarker 
(sample, mean ± 
SD or median 
(IR), timing)  
Main results 
NOS 
scores 
FATTY ACIDS      
Outcomes in pregnancy     
Pinto et al., 2016, 
Brazil 
1, 2
 
Cohort, 
n = 172, 
NR mean 
age 
33.7% at 5
th
-13
th
 
gw, 18.9% at 
20
th
-26
th
 gw and 
17.4% at 30
th
-
36
th
 gw scored ≥ 
11 in Portuguese 
version of 
EPDS. 
In serum (g/mL): 
LA = 705.3 ± 
127.9, AA = 211.0 
± 50.9, AdA = 9.1 
± 3.4, ALA= 14.9 
± 5.3, EPA = 9.9 
± 5.4, DPA = 12.2 
± 3.7, DHA = 
56.4 ± 15.9, total 
ω-6 PUFA = 
993.2 ± 176.2 and 
total ω-3 PUFA = 
93.6 ± 25.4 at 5
th
-
13
th
. Fatty acids 
were also 
measured at 20
th
-
26
th
 and 30
th
-36
th
 
gw. 
ORs (95% CI) 
(within effect, 
random intercept 
logistic model, 
longitudinal 
data) of 
depression 
symptoms 
during 
pregnancy and 
levels of serum 
fatty acids were: 
1.0 (1-1.01) for 
LA, 1.0 (0.99-
1.02) for AA, 
0.94 (0.81-1.08) 
for AdA, 0.97 
(0.90-1.04) for 
ALA, 0.92 
(0.86-0.99) for 
EPA, 0.87 (0.77-
0.99) for DPA, 
0.96 (0.93-0.99) 
for DHA, 1.40 
(1.09-1.79) for 
ω-6/ω-3, 1.0 
(1.0-1.0) for 
total ω-6 PUFA, 
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0.98 (0.96-0.99) 
for total ω-3 
PUFA. All 
models were 
adjusted for 
gestational age, 
previous history 
of depression, 
marital status, 
inter-partum 
interval, pre-
pregnancy BMI 
and planned 
pregnancy. 
Hamazaki et al., 
2016, Japan  
Nested 
case-
control, 
n = 283: 
283, case 
group= 
31.5 ± 
5.0; control 
group= 
31.5 ± 
4.9  yr 
Cases scored ≥ 9 
in Japanese 
version of the 
Kessler 
psychological 
distress scale at 
first trimester. 
In serum (%): for 
case group EPA = 
0.53 (0.41-0.79), 
DPA = 0.42 (0.33-
0.53) and DHA = 
3.39 (2.73-4.06); 
for control group 
EPA  = 0.62 
(0.46-0.94), 
DPA= 0.45 (0.37-
0.56) and DHA = 
3.56 (2.95-4.09) at 
9
th
-14
th
 gw and 
25% after 15
th
 gw 
ORs (95% CI) 
of psychological 
distress in early 
pregnancy were 
for the highest 
versus lowest 
serum tertiles: 
0.47 (0.30-0.73) 
for EPA, 0.73 
(0.48-1.13) for 
DPA, 0.79 
(0.52-1.22) for 
DHA. Results 
were adjusted 
for parity, 
smoking status, 
alcohol intake, 
BMI, 
medication, 
occupation, 
physical activity, 
marital status 
and having 
pregnancy-
associated 
nausea. 
8 
Rees et al., 2009, 
Australia  
Case-
control, 
n = 16: 
22, case 
group= 
32.4 ± 
4.8; control 
group= 
33.13 ± 
3.3 yr 
Cases met the 
criteria of one 
episode of major 
depression by 
DSM-IV criteria, 
and confirmed 
by both CIDI 
structured 
interview and 
psychiatrist 
clinical 
assessment, or 
scored ≥ 13 in 
EPDS, or > 14 in 
HDRS or > 25 in 
MADRS
 
in the 
third trimester. 
In plasma (%): for 
case group total 
ω-3 PUFA = 6.9 ± 
1.5, ALA = 0.2 ± 
0.1, DHA = 5.0 ± 
1.5, EPA = 0.6 ± 
0.3, total ω-6 
PUFA = 33.9 ± 
2.2, AA = 9.8 ± 
1.6 and DPA = 0.5 
± 0.2; for control 
group total ω-3 
PUFA = 8.1 ± 1.9, 
ALA = 0.2 ± 0.1, 
DHA = 6.3 ± 1.4, 
EPA = 0.7 ± 0.5, 
total ω-6 PUFA = 
32.3 (2.6), AA = 
ORs (95% CI) 
of depression in 
third  trimester 
were for high 
(>median) vs. 
low plasma fatty 
acids levels: 
0.21 (0.05–0.99) 
for total ω-3 
PUFA, 1.45 
(0.33–6.50) for 
ALA, 0.18 
(0.04–0.88) for 
DHA,  1.55 
(0.34–7.08) for 
EPA, 2.28 
(0.49–10.55) for 
total ω-6 PUFA, 
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9.5 ± 5.4 and DPA 
= 0.6 ± 0.3 at third 
trimester. 
2.73 (0.52–
14.40) for AA,  
1.74 (0.40–7.64) 
for DPA, 4.69 
(1.00–21.99) for 
ω-6/ω-3, 0.75 
(0.16–3.58) for 
AA/EPA, (0.47 
(0.10–2.14) for 
DHA/DPA. 
Results were 
adjusted for age, 
education and 
parity. 
Mattes et al., 2009, 
Australia  
Cross-
sectional, 
n = 81, 
31.7 ± 
3.8 yr 
22.2% scored ≥ 
10 in BDI at 20
th
 
gw. 
In red blood cell 
(%), for BDI < 10: 
total ω-3 PUFA = 
16.1 ± 1.6 and 
total ω-6 PUFA = 
25.3 ± 1.3; for 
BDI ≥ 10: total ω-
3 PUFA = 15.4 ± 
2.0 and total ω-6 
PUFA = 26.0 ± 
1.2 at 20
th
 gw. 
βlogistic regression of 
depression as 
BDI scored ≥ 10 
at 20
th
 wk were -
0.29 (P = 0.10), 
0.45 (P = 0.051) 
and -6.52 (P = 
0.06) for a 1-unit 
increment of red 
blood cell total 
ω-3 PUFA, total 
ω-6 PUFA and 
ω-3/ ω-6 ratio, 
respectively. 
Results were 
adjusted for 
maternal age, 
education and 
parity. 
7 
Shiraishi et al., 
2015, Japan
 
 
Cross-
sectional, 
n = 329, 
34.7 ± 
4.01 yr 
5.8% scored > 8 
in the Japanese 
version of EPDS 
at 19
th
-23
th
 gw. 
In plasma 
(g/ml): for EPDS 
> 8 EPA = 21 
(13–39) and DHA 
= 107 (81–128); 
for EPDS ≤ 8 
EPA = 25 (17–38) 
and DHA = 125 
(105–148) at19th-
23
th
 gw. 
βlogistic regression of 
depression as 
EPDS scored > 
8 in middle 
pregnancy were 
-1.064 (P = 
0.28) and -4.894 
(P = 0.01) for a 
1-unit increment 
of plasma EPA 
and DHA levels, 
respectively. 
Results were 
adjusted for age 
and the presence 
of pregnancy-
associated 
nausea. 
6 
Vaz et al., 2014, 
Brazil 
1
 
Cross-
sectional, 
n = 194, 
range 
20–40 yr 
17% major 
depressive 
episode by Mini 
International 
Neuropsychiatric 
Interview DSM-
In serum (%): LA 
= 30.8 ± 3.4, AA 
= 9.2 ± 1.6, AdA= 
0.38 ± 0.09, ω-6 
HUFA = 78.2 ± 
3.8, ALA= 0.62 ± 
ORs (95% CI) 
of major 
depressive 
episode in the 
first trimester for 
an increase in 1-
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IV at 6
th
-13
th
 gw. 0.13, EPA= 0.42 ± 
0.21, ω-3 DPA= 
0.53 ± 0.10, 
DHA= 2.4 ± 0.5, 
ω-3 HUFA = 21.7 
± 3.8, total MUFA 
= 20.5 ± 2.2 and 
total SFAs= 31.9 
± 1.6 at 6
th
-13
th
 
gw. 
unit of z score of 
serum fatty acids 
levels were: 0.74 
(0.52-1.06) for 
LA, 1.47 (1.03-
2.10) for AA, 
1.59 (1.09-2.32) 
for AdA, 1.25 
(0.82-1.90) for 
ω-6 HUFA, 0.80 
(0.56-1.14) for 
ALA, 1.02 
(0.69-1.40) for 
EPA, 1.01 (0.70-
1.47) for ω-3 
DPA, 1.06 
(0.72-1.55) for 
DHA, 0.80 
(0.52-1.21) for 
ω-3 HUFA, 1.14 
(0.79-1.64) for 
total MUFA and 
1.10 (0.76-1.58) 
for total SFA. 
Results were 
adjusted for 
marital status, 
current smoking 
habit, close 
relatives and gw. 
Verly-Miguel et 
al., 2015, Brazil 
1
 
Cross-
sectional, 
n = 228, 
range 
20–40 yr 
25% of at least 
one anxiety 
disorder by Mini 
International 
Neuropsychiatric 
Interview DSM-
IV at 5
th
-13
th
 gw. 
In serum (g/mL): 
ALA, EPA, ω-3 
DPA, DHA, total 
ω-3 PUFA, LA, 
AA, AdA and 
total ω-6 PUFA 
(NR means) at 5
th
-
13
th
 gw (NR 
means). 
ORs (95% CI) 
of anxiety 
disorders in the 
first trimester for 
the lowest tertile 
of serum fatty 
acids levels 
were: 1.27 
(0.64-2.55) for 
ALA, 0.93 
(0.48-1.82) for 
EPA, 1.18 (0.61-
2.27) for ω-3 
DPA, 1.95 (1.00 
-3.77) for DHA, 
1.76 (0.91-3.40) 
for total ω-3 
PUFA, 1.47 
(0.76-2.84) for 
LA, 0.93 (0.47-
1.82) for AA, 
0.98 (0.48-1.97) 
for AdA, 1.03 
(0.53-2.01) for 
total ω-6 PUFA, 
1.53 (0.79-2.95) 
for ω-6/ ω-3. 
Results were 
adjusted for 
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parity, per-capita 
family income, 
early pregnancy 
body mass index 
and gestational 
age at the blood 
sampling. 
Outcomes in postpartum     
Markhus et al., 
2013, Norway 
3
 
Cohort, 
n = 44, 
29.5 ± 
5.0 yr 
6.9% scored ≥ 
10 in Norwegian 
version EPDS at 
third postnatal 
mo. 
In red blood cell 
(%): total SFA = 
39.2 ± 2.5, total 
MUFA = 18.7 ± 
2.0, AA= 11.2 ± 
1.7, ALA= 0.3 ± 
0.1, EPA= 0.7 ± 
0.4, DPA= 1.7 ± 
0.5, DHA= 5.7 ± 
1.4 at 28
th
 gw. 
Pearson 
correlations 
between EPDS 
score and red 
blood cell fatty 
acids levels 
were: 0.12 (P = 
0.43) for total 
SFAs, 0.20 (P = 
0.20) for total 
MUFAs, -0.20 
(P = 0.21) for 
AA, 0.08 (P = 
0.59) for ALA, -
0.26 (P = 0.10) 
for EPA, -0.35 
(P = 0.02) for 
DPA, 0.41 (P = 
0.006) for DHA, 
0.31 (P = 0.04) 
for ω-3/ω-6 
ratio. 
5 
Otto et al., 2003, 
Netherlands 
Cohort, 
n = 112, 
30.66 ± 
3.28 yr 
21% scored ≥ 10 
in Dutch version 
EPDS at 32
th
 
postnatal wk. 
In plasma (%) at 
delivery for ω-3 
DHA= 3.91 ± 
0.94, ω-6 DPA= 
0.47 ± 0.19, also 
measured at 32
th
 
postnatal wk (NR 
%). 
Spearman 
correlation 
between EPDS 
score and 
plasma fatty 
acids levels 
were: (a) at 
delivery: - 0.06 
(P = 0.563) for 
DHA, -0.01 (P = 
0.927) for ω-6 
DPA, -0.01 (P = 
0.91) for 
DHA/ω-6 DPA; 
(b) Postnatal 
change 
(difference 
between at 
delivery and 32
th 
postnatal wk 
values): 0.04 (P 
= 0.694) for 
DHA, 0.04 (P = 
0.681) for DPA, 
-0.08 (P = 0.43) 
for DHA/ω-6 
DPA.  
6 
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OR of 
depression as 
EPDS score ≥ 10 
was 0.88 (P = 
0.03) for 1-unit 
increase of 
postnatal change 
for plasma 
DHA/ω-6 DPA. 
Results were 
adjusted for 
parity, 
educational 
level, maternal 
age at test 
moment, breast/ 
bottle-feeding, 
smoking and 
alcohol use.  
Parker et al., 2015, 
Australia 
Cohort, 
n = 895, 
31.0 ± 
5.7 yr 
19.8% at 36
th
 gw 
and 17.8% third 
postnatal mo 
scored ≥ 10 in 
EPDS.  
In red blood cell 
(%): total SFA = 
44.8 ± 1.3, total 
ω-6 PUFA = 26.8 
± 1.8, total ω-3 
PUFA = 9.3 ± 1.7, 
ω-3 DHA = 6.1 ± 
1.2, ω-3 DPA = 
2.2 ± 0.3, EPA = 
0.58 ± 0.37 and 
AA = 11.8 ± 1.0 
at 36
th
 gw. 
Pearson´s 
correlations 
between third 
postnatal mo 
EPDS scores 
and red blood 
cell fatty acids 
levels were: 
0.003 for total 
SFAs, 0.03 for 
total ω-6 PUFA, 
-0.017 for total 
ω-3 PUFA, 
0.020 for ω-6/ω-
3, -0.012 for ω-3 
DHA, -0.019 for 
ω-3 DPA, -0.025 
for EPA, -0.016 
for DHA+EPA, 
-0.023 for AA. 
All correlations 
presented P > 
0.05.  
ORs of 
depression as 
EPDS score ≥ 10 
were 1.1 (P < 
0.05) for lower 
total ω-3 PUFA, 
2.7 (P < 0.05) 
for lower EPA 
and 1.1 (P < 
0.05) for higher 
total ω-6 PUFAs 
levels. Results 
were adjusted 
for neuroticism 
scores, stress 
during 
pregnancy, a 
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lifetime 
depressive 
episode and 
older age.   
Outcomes in pregnancy and 
postpartum  
  
 
Chong et al., 2015, 
Singapore 
4
 
Cohort, 
n = 698, 
30.8 ± 
5.2 yr 
7.2% scored ≥ 
15 in the EPDS 
at 26
th
-28
th
 gw 
and 10.3% 
scored ≥ 13 in 
the EPDS at the 
third postnatal 
mo. Anxiety by 
STAI-state 
subscale at same 
time.  
In plasma 
(g/mL): total ω-3 
PUFA = 142.4 
(36.2-690.4) and 
ω-6 PUFA = 
799.4 (271.8-
2.186.3) at 26
th
-
28
th
 gw.  
βlinear regression of 
anxiety scores 
were for log-
transformed 
plasma fatty 
acids levels: -
6.49 (P = 0.019) 
for total ω-3 
PUFA, 5.03 (P = 
0.196) for total 
ω-6 PUFAs 
(these last two 
were analyzed in 
the same model), 
6.58 (P = 0.017) 
for ω-6/ ω-3, 
7.54 (P = 0.004) 
for AA/DHA, 
3.44 (P = 0.013) 
for AA/EPA, 
5.36 (P = 0.025) 
for AA/DPA, 
5.62 (P = 0.061) 
for AA/DHA, 
1.96 (P = 0.269) 
for AA/EPA and 
0.95 (P = 0.765) 
for AA/DPA 
(these last three 
were analyzed in 
the same model) 
at 26
th
-28
th
 gw. 
For third 
postnatal mo 
were for log-
transformed 
fatty acids 
levels: -0.42 (P 
= 0.874) for total 
ω-3 PUFA, 0.25 
(P = 0.948) for 
total ω-6 PUFA 
(these last two 
were analyzed in 
the same model), 
0.44 (P = 0.870) 
for ω-6/ ω-3, 
0.63 (P = 0.805) 
for AA/DHA, -
0.50 (P = 0.708) 
for AA/EPA, -
0.72 (P = 0.753) 
for AA/DPA, 
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1.38 (P = 0.633) 
for AA/DHA,  -
0.51 (P = 0.763) 
for AA/EPA and 
-0.75 (P = 
0.805) for 
AA/DPA (these 
last three were 
analyzed in the 
same model). 
ORs (95% CI) 
of depression for 
log-transformed 
fatty acids levels 
were: 1.40 
(0.29-6.73) for 
total ω-3 PUFA, 
4.48 (0.51-
39.68) for total 
ω-6 PUFA, 2.75 
(0.27-27.87) for 
ω-6/ ω-3, 1.71 
(0.18-16.02) for 
AA/DHA, 1.66 
(0.52-5.36) for 
AA/EPA, 2.36 
(0.32-17.37) for 
AA/DPA; and 
1.05 (0.08-
13.44) for 
AA/DHA, 1.38 
(0.31-6.18) for  
AA/EPA, 1.65 
(0.12-23.39) for 
AA/DPA (these 
last three were 
analyzed in the 
same model) at 
26
th
-28
th
 gw. For 
third postnatal 
mo were: 1.48 
(0.40-5.55) for 
total ω-3 PUFA, 
1.63 (0.24-
10.97) for total 
ω-6 PUFA, 0.70 
(0.09-5.14) for 
ω-6/ ω-3, 0.90 
(0.13-6.32) for 
AA/DHA, 0.80 
(0.30-2.13) for 
AA/EPA, 1.73 
(0.30-10.04) for 
AA/DPA, 0.74 
(0.08-6.69) for 
AA/DHA, 0.54 
(0.16-1.85) for 
AA/EPA, 3.81 
(0.39-37.06) for 
AA/DPA (these 
51 
 
last three were 
analyzed in the 
same model). 
All results were 
adjusted for 
ethnicity, parity, 
education level, 
marital status, 
maternal body 
mass index at 
26
th
-28
th
 gw, 
maternal age, 
employment 
status, maternal 
and infant health 
status, smoking 
status, alcohol 
consumption, 
history of 
abortion, 
miscarriage and 
stillbirth, 
frequency of 
exercise, and 
reported fish oil 
supplementation. 
For third 
postnatal mo, 
results were 
further adjusted 
infant sex, mode 
of delivery, and 
respective STAI 
or EPDS scores 
at 26
th
-28
th
 gw.  
Sallis et al., 2014, 
United Kingdom 
5
 
Cohort, 
n = 
3,397, 
28.9 ± 
4.5 yr 
11.5% perinatal 
onset of 
depression 
defined as 
scored > 12 in 
the EPDS at 32
th
 
gw and 8
th
 
postnatal wk 
(without 
diagnosing at 
18
th
 gw).  
In red blood cell 
(%): EPA = 0.27 
± 0.16 and DHA = 
2.31 ± 1.33 after 
20
th
 gw. 
ORs (95% CI): 
a) of perinatal 
onset for red 
blood cell fatty 
acid levels were: 
1.07 (0.99-1.15) 
for EPA and 
1.08 (0.98-1.19) 
for DHA; b) of 
antenatal 
depression were: 
0.97 (0.91-1.04) 
for EPA and 
0.99 (0.91-1.07) 
for DHA; c) of 
postnatal 
depression were 
1.04 (0.96-1.13) 
for EPA and 
1.04 (0.94-1.15) 
for DHA. All 
results were 
adjusted for 
social class and 
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maternal age. 
CHOLESTEROL      
Outcomes in pregnancy    
Teofilo et al., 
2014, Brazil 
1, 6
 
Cohort, 
n = 238, 
range 
20–40 yr 
34.4% scored ≥ 
11 in the 
Brazilian version 
of EPDS at 5
th
-
13
th
 gw, 21.5% 
at 20
th
-26
th
 gw 
and 21.5% at 
30
th
 -36
th
 gw. 
Serum HDL-
cholesterol mean 
(95% CI) 47.7 
(46.5-49.0) for 
EPDS < 11 and 
47.5 (45.7-49.3) 
(mg/dL) for EPDS 
≥ 11 at 5th-13th 
gw. It was also 
measured at 20
th
-
26
th
 and 30
th
-36
th
 
gw. 
βlongitudinal linear 
regression (95% CI) 
was -0.080 (-
0.157-0.002, P = 
0.043) for a 1-
unit increase of 
serum HDL-
cholesterol when 
longitudinal 
changes 
throughout 
pregnancy of 
EPDS scores. 
Results were 
adjusted for age, 
education, 
marital status, 
physical activity, 
work outside 
home, parity, 
unplanned 
pregnancy, 
generalized 
anxiety disorder, 
current suicidal 
ideation, global 
physical 
violence, LDL-
Cholesterol, pre-
pregnancy BMI 
and gestational 
age. 
8 
Outcomes in postpartum     
Ploeckinger et al., 
1996, Italy 
Cohort, 
n = 20, 
25.3 3.7 
yr 
Means ± SD: day -
14 = 33.8 ±7.3, 1st 
day postnatal = 33.6 
± 8.0, 2nd day = 
32.1 ± 7.6, 3rd day 
= 30.0 ± 7.3, 4th 
day = 29.7 ± 7.9 
by Zung self-
rating depression 
scale at second 
wk before the 
expected 
delivery and 
daily from the 1
st
 
to 4
th
 postnatal 
day. 
Serum cholesterol 
= 6.52 ± 1.19 at 
second wk before 
the expected 
delivery, 5.40 ± 
0.88 at first 
postnatal day and 
5.92 ± 1.58 
(mmol/L) at third 
postnatal day. 
Pearson 
correlations 
between the 
Zung self-rating 
scale scores 
(assessed in 
postnatal days 1-
4) and relative 
changes in 
serum 
cholesterol from 
pre-partum to 
postnatal were: 
(a) from second 
wk before 
delivery to first 
postnatal day for 
cholesterol 
3 
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measurements: -
0.30 (P = 0.47) 
on day 1, -0.73 
(P = 0.02) on 
day 2, -0.73 (P = 
0.02) on day 3, 
and -0.68 (P = 
0.03) on day 4; 
(b) from second 
wk before 
delivery to third 
postnatal day for 
cholesterol 
measurements: -
0.75 (P = 0.01) 
on day 2, -0.74 
(P = 0.01) on 
day 3 and -0.63 
(P = 0.05) on 
day 4. 
van Dam et al., 
1999, Netherlands 
7
 
Cohort, 
n =305, 
29 ± 3.3 
yr 
23.6% with 
depression by 
Research 
Diagnostic 
Criteria at 10
th
-
34
th
 postnatal 
wk. 
Serum cholesterol 
at 32
th
 gw and 10
th
 
postnatal wk (NR 
means). 
OR (95% CI) of 
depression 
between the 
10
th
-32
th
 
postnatal wk for 
the highest (> 
1.6 mmol/l) 
versus lowest 
tertiles (< 0.9 
mmol/l) of 
serum 
cholesterol 
decline was 1.4 
(0.64-2.9). 
Results were 
adjusted for age, 
parity, education 
level, smoking 
status, 
concurrent 
illness, and 
social support. 
8 
Grussu et al., 
2007, Italy 
8
 
Cross-
sectional, 
n = 209, 
range 25 
– 41 yr 
Mean ± SD 
Depression = 2.5 ± 
2.8 by Kellner 
Symptom 
Questionnaire at 
third postnatal 
day. 
Serum cholesterol 
= 6.3 ± 1.4 
(mmol/L) at third 
postnatal day. 
Spearman 
correlation 
between the 
serum 
cholesterol 
levels and 
depression scale 
scores was -0.15 
(P < 0.05) in 
third postnatal 
day. 
5 
Outcomes in pregnancy and 
postpartum  
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Troisi et al., 2002, 
Italy 
Cohort, 
n = 47, 
29.4 ± 
3.8 yr 
Mean ± SD: in 
late pregnancy: 
STAI = 33.30 ± 
7.41 and BDI = 
7.32 ± 3.13. In 
early postnatal: 
STAI = 33.85 ± 
8.45 and BDI = 
6.64 ± 5.10. 
In serum (mg/dL): 
total cholesterol = 
290.91 ± 44.40 
and HDL-
cholesterol = 
71.13 ± 17.97 at 
late pregnancy 
(median = -20 day 
before expected 
delivery, range: -
52- -1); total 
cholesterol = 
235.19 ± 43.69 
and HDL-
cholesterol = 
62.75 ± 13.78 at 
early postnatal 
(median = 32 day 
after delivery, 
range: 16-56). 
Pearson 
correlations 
were: (a) 
Antenatal: 
between serum 
total cholesterol 
and STAI -0.04 
(P = 0.77), and 
BDI -0.19 (P = 
0.21); between 
HDL-cholesterol 
and STAI -0.15 
(P = 0.33), and 
BDI -0.29 (P = 
0.053). (b) 
Postnatal: 
between total 
cholesterol and 
STAI -0.29 (P = 
0.05), and BDI -
0.34 (P = 0.02); 
between HDL-
cholesterol and 
STAI -0.34 (P = 
0.02), and BDI -
0.25 (P = 0.10); 
c) between 
relative changes 
in total 
cholesterol 
levels from 
antenatal to 
postnatal and 
postnatal STAI 
0.15 (P = 0.33), 
and postnatal 
BDI -0.26 (P = 
0.08). All results 
were adjusted 
for the day of 
assessment 
before delivery. 
4 
Patterns of fatty acids, carotenoids and micronutrients and outcome 
in pregnancy 
  
Bodnar et al., 
2012, USA 
9
 
Cohort, 
n =135, 
range 18-
43 yr 
 
21.5% major 
depressive 
disorder by 
Structured 
Clinical 
Interview for 
DSM-IV at 20
th
, 
30
th
 and 36
th
 gw. 
In red blood cell 
(%): DHA = 2.80 
(2.36-3.33), AA = 
11.8 (10.7-13.1), 
EPA = 0.30 (0.26-
0.34). 
In plasma 
geometric mean 
(95% CI) 
(nmol/L): folate = 
31.5 (28.9-34.3), 
ascorbic acid = 
66.1 (61.6-70.8), 
ORs (95% CI) 
of major 
depressive 
disorder during 
pregnancy (3 
points) were 0.8 
(0.3-2.1), 1.4 
(0.5-3.8) and 0.8 
(0.3-2.1) in the 
highest versus 
lowest tertiles of 
essential fatty 
acids, 
micronutrients 
7 
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Hcy = 2.32 (2.17-
2.48) (mol/L).  
In serum 
geometric mean 
(95% CI) 
(nmol/L): retinol 
= 1649 (1580-
1721), 25-
hydroxyvitamin D 
= 81.9 (75.1- 
89.3), α-
tocopherol= 161 
(156-165), β-
carotene = 162 
(127-206), 
Lutein+zeaxanthin 
= 102 (90.5-114), 
β-cryptoxanthin = 
132 (110-158), 
lycopene= 541 
(489- 598), 
soluble transferrin 
receptors = 15.6 
(14.5-15.9) 
(mol/L). All 
biomarkers were 
measured at ≤ 20 
gw. 
and carotenoids 
scores, 
respectively, 
adjusted for 
study visit 
number, 
employment, 
education and 
pre-pregnancy 
BMI. 
Abbreviations: AA = arachidonic acid; AdA = adrenic acid; ALA = α-linolenic acid; BDI = Beck 
Depression Inventory; CI = confidence interval; CIDI = Composite International Diagnostic 
Interview; DHA = docosahexaenoic acid; DMS-IV = Diagnostic and Statistical Manual of Mental 
Disorders; DPA = docosapentaenoic acid; EPA = eicosapentaenoic acid; EPDS = Edinburgh Postnatal 
Depression Scale; gw = gestational week; h = hour; HDRS = Hamilton Depression Rating scale; 
HUFA = highly unsaturated fatty acids; IR = interquartile range; LA = linoleic acid; MADRS = 
Montgomery-Asberg Depression Rating Scale; mo = month; MUFA = monounsaturated fatty acids; 
NOS = Newcastle-Ottawa scale; NR =not reported; PUFA = polyunsaturated fatty acids; SD = 
standard deviation; SFA = saturated fatty acids; STAI = Spielberger’s State-Trait Anxiety Index; wk = 
week; yr = year.  
1
 These studies were based on data from the same primary research. 
2
 Enrollment and follow-up lasted between November 2009 and July 2012. 
3 
Women reported to consume 3 supplements on average 4.9 ± 3.0 times per week. 
4 
Participants were Singaporean citizens or permanent residents of Chinese, Malay or Indian ethnicity 
with parents of homogenous ethnicity background. 93.1% and 93.0% of women took folic acid and 
vitamin B12 supplements, respectively. 
5
 Women included in the analysis were of self-reported White European ethnicity.  
6 
A subsample of 41 women participated in a clinical trial of treatment of 1.08 g EPA+ 0.72 g DHA 
per day and placebo for 16 weeks after the 22
th
-24
th 
gestation week (this sample was excluded in Pinto 
et al., 2016). 
7
 Participants were white women. 
8 
The sample size was 356 women, but only 209 mothers were in the traditional after-delivery nursing 
care group showed data of interest. 
9
 Bodnar et al., 2012 studied several biomarkers simultaneously by estimating factor scores for fatty 
acids, micronutrients and carotenoids.  
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Table 3. Characteristics of included studies evaluating the associations between 
micronutrients and amino acids and psychological distress in women during pregnancy and 
the first postpartum year. 
Study, country 
Study 
design, 
sample 
size and 
age 
(mean ± 
SD) 
Psychological 
distress (%, 
assessment 
tool, timing) 
Nutritional 
biomarker 
(sample, mean ± 
SD or median 
(IR), timing)  
Main results 
NOS 
scores 
VITAMIN D     
 
Outcomes in pregnancy    
Brandenbarg et 
al., 2012, 
Netherlands 
1
 
Cohort, 
n = 
4,101, 
31.0 ± 
4.8 yr 
28% scored ≥ 
16 in CESD 
scale at 
median (IR) = 
16
th
 (14
th
-18
th
) 
gw. 
Serum vitamin D 
= 57.0 ± 30.8 
(nM) at median 
(IR) = 13 (12-14) 
gw. 
ORs (95% CI) of 
high levels of 
depressive 
symptoms (scored 
≥ 16 CESD) in 
middle pregnancy 
were 1.48 (1.13-
1.95), 1.44 (1.12-
1.85), 1.21 (0.97-
1.51) for women 
in the deficient (< 
29 nM), 
insufficient 
(between 30-49.9 
nM) and 
sufficient (50-
79.9 nM) 
categories of 
serum vitamin D 
levels, 
respectively, in 
relation to normal 
as reference (≥ 80 
nM). Results 
were adjusted for 
maternal age, 
parity and 
ethnicity, life-
style, 
psychosocial and 
sociodemographic 
variables. 
8 
Cassidy-
Byshrow et al., 
2012, USA 
 2, 3, 4, 
5
 
Cohort, 
n = 178, 
26.7 ± 
6.0 yr 
41.6% scored 
≥ 16 in CESD 
scale at mean 
(SD) = 20.8 
(3.7) gw.  
Serum vitamin D 
= 13.4 ± 8.4 
(ng/mL) at mean 
± SD= 9.5 ± 3.6 
gw. 
OR (95% CI) of 
CESD score ≥ 16 
in pregnancy was 
0.54 (0.29-0.99) 
per unit increase 
of log-
transformed 
8 
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serum vitamin D 
levels in women. 
Results were 
adjusted for 
maternal age, 
high-school 
education, marital 
status, season of 
vitamin D 
measurement, and 
number of days 
between vitamin 
D and CESD 
measures. 
Huang et al., 
2014, USA 
6
 
Cross-
sectional, 
n = 498, 
33.4 ± 
4.2 yr 
12.2% scored 
> 10 for 
depression in 
PHQ-9, 
12.4% scored 
> 10 for 
anxiety in 
DASS and 
7.6%  scored 
> 19 for stress 
in DASS at 
mean = 15.4 ± 
2.6 gw. 
Serum vitamin D 
= 34.4 ± 8.7 
(ng/mL) at mean 
± SD 15.4 ± 2.6 
gw. 
βlinear regression were: 
0.017 (P = 0.547) 
for increase in 
DASS-21 
depression score, 
0.019 (P = 0.398) 
for difference in 
DASS-21 anxiety 
score, 0.037 (P = 
0.281) for 
difference in 
DASS-21 stress 
score, 0.019 (P = 
0.335) for 
difference in 
PHQ-9 per 1 
ng/ml decrease in 
serum vitamin D 
during pregnancy. 
All results were 
adjusted for 
season, 
gestational age at 
blood draw, age 
at enrolment, pre-
pregnancy BMI, 
smoking status, 
white race, 
education and 
marital status. 
8 
Outcomes in postpartum    
Accort et al., 
2016, USA 
2, 3, 4, 
7
 
Cohort, 
n = 91, 
26.0 ± 6 
yr 
12% scored 
≥12 in the 
EPDS score at 
4
th
-6
th
 
postnatal wk 
(mean = 4.5 ± 
1.8). 
Serum vitamin 
D= 13.2 ± 9.4 
(ng/mL) at first 
prenatal visit 
(mean = 9.7 ± 3.7 
gw). 
β linear regression was 
-0.209 (P = 
0.058) for EPDS 
score 3-4
th
 
postnatal wk by a 
1-unit increase of 
log-transformed 
serum vitamin D 
levels. Results 
were adjusted for 
maternal age, 
education, marital 
8 
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status, history of 
depression, 
season of vitamin 
D measurement 
and pre-
pregnancy BMI. 
Fu et al., 2015, 
China 
8
 
Cohort, 
n = 213, 
mean 
(IR) = 31 
(29-32) 
yr 
12.2% scored 
≥ 12 in 
Chinese 
version of 
EPDS at third
 
postnatal mo. 
Serum vitamin D 
median (IR) = 
13.8 (9.4–17.1) 
(ng/mL) at 24-48 
postnatal h. 
OR (95% CI) of 
depression (as 
scored ≥ 12 in 
EPDS) at third 
postnatal mo was 
0.81 (0.70-0.92) 
by a 1-unit 
increase of serum 
vitamin D levels. 
Results were 
adjusted for age, 
breastfeeding, 
stressful life 
events, maternal 
education, family 
income, partner 
support, planned 
versus unplanned 
pregnancy, mode 
of delivery and 
previous 
psychiatric 
contact. 
7 
Gur et al., 2014, 
Turkey 
 9,10, 11
 
Cohort, 
n = 208, 
28.5 yr 
21.1% at first 
postnatal wk, 
23.2% at 6
th
 
wk and 23.7% 
at 6
th
 mo 
scored ≥ 12 in 
EPDS. 
Serum vitamin D 
= 22.4 ± 11.2 
(ng/mL) at
 
24
th
-
28
th
 gw. 
Pearson 
correlations 
between serum 
vitamin D levels 
and EDPS scores 
were: -0.2 (P = 
0.02), -0.2 (P = 
0.01) and -0.3 (P 
< 0.01) at first
 
postnatal wk, 6
th
 
wk and 6
th
 mo, 
respectively. 
6 
Robinson et al., 
2014, Australia 
12
 
Cohort, 
n = 929, 
NR mean 
age 
Postnatal 
depression 
symptoms: 
None 
symptoms = 
28.0%, 1–5 
symptoms = 
50.4%, 6+ 
symptoms = 
21.5% by six 
questions 
derived from 
the EPDS in 
third
 
postnatal 
day. 
Serum vitamin D 
at 18
th
 gw (NR 
means). 
ORs (95% CI) of 
women with more 
than 6 depression 
symptoms in 
EDPS score in the 
third postnatal 
day were 2.72 
(1.42-5.22), 1.37 
(0.71-2.63), 1.61 
(0.83-3.10) in the 
first (<47 
nmol/L), second 
and third in 
relation to the 
fourth (>70 
mmol/L) quartile 
8 
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of serum vitamin 
D levels. Results 
were adjusted for 
pre-pregnancy 
body mass index, 
maternal age, 
maternal 
education, total 
family income, 
maternal 
smoking, 
maternal alcohol 
intake, 
hypertensive 
diseases of 
pregnancy, 
proportion of 
optimal birth 
weight, child sex, 
special care 
nursery admission 
and season of 
birth. 
VITAMIN B and AMINO ACIDS    
Outcomes in pregnancy    
Watanabe et al., 
2010, Japan 
13
 
Cross-
sectional, 
n = 86, 
30.9 ± 
4.6 yr 
61.6% scored 
≥ 16 in 
Japanese 
version CESD 
at 6
th
-11
th 
gw. 
Serum folate: 
median (IR)non-
depressed = 8.0 
(5.5), median 
(IR)depressed = 8.2 
(4.5) (ng/mL); 
plasma Hcy : 
median (IR)non-
depressed = 6.0 
(2.4), 
median(IR)depressed 
= 6.1 (1.4) at 4
th
-
11
th
 gw. 
ORs (95% CI) of 
depression as 
scored ≥ 16 in 
CESD at first 
trimester were 
0.63 (0.24-1.61) 
and 0.63 (0.23-
1.72) in women 
with serum folate 
levels < 8.1 
ng/mL and Hcy 
levels ≥ 6.1 
mmol/mL, 
respectively. 
Results were 
adjusted for 
parity, number of 
vomits/day and 
gestational age.  
6 
Outcomes in postpartum    
Blunden et al., 
2012, United 
Kingdom
 
 
14, 15
 
Cohort, 
n = 
2,856, 
NR mean 
age 
32% scored > 
13 in EPDS at 
6
th
-12
th
 
postnatal mo. 
Red blood cell 
folate geometric 
mean (95% CI) = 
2413 (2365-
2461) (nmol/L) at 
11
th
 gw. 
RR (95% CI) of 
depression as 
EPDS score ≥ 13 
at 6-12
th
 postnatal 
mo was 1.0 (1.0-
1.0) for an 
increase of 10 
units in the red 
blood cell folate 
6 
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levels. 
Handley et al., 
1977, United 
Kingdom 
Cohort, 
n = 18, 
range 18-
31 yr 
NR %, 
diagnosed by 
MAACL at 
2
nd
-5
th
 
postnatal
 
day. 
Plasma free Trp, 
mean ± SE = 6.9 
± 1.4, 8.0 ± 0.7, 
7.9 ± 0.5, 9.0 ± 
0.7 (mol/L) at 
2
nd
-5
th
 postnatal 
day. 
Spearman´s 
correlation 
between MAACL 
depression score 
at 2-5
th
 postnatal 
day and plasma 
free Trp levels 
was -0.3 (P < 
0.01). 
4 
Handley et al., 
1980, United 
Kingdom  
Cohort, 
n = 71, 
range 17-
39 yr 
39% scored at 
least one of 
the scales on 
≥ 11 Blues 
index, ≥ 15 
BDI, ≥ 22 
MAACL and 
≥ 7 VAS at 
1
st
-5
th
 
postnatal day. 
Plasma total Trp 
at first postnatal 
day (NR means). 
Spearman´s 
correlation 
between BDI 
score at 1-5
th
 
postnatal day and 
plasma Trp levels 
was -0.2069 (P = 
0.141). 
6 
Stein et al., 
1976, United 
Kingdom  
Cohort, 
n = 18, 
mean ± 
SE = 
27.4 ± 
1.2 yr 
Mean ± SE = 
2.35 ± 0.42 of 
affective 
score by the 
rank number 
of symptoms 
(tearfulness, 
depression, 
anxiety, 
appetite and 
insomnia) in 
7
th
-8
th
 
postnatal day. 
Plasma total Trp 
mean ± SE= 84.7 
± 2.3 (mol/L) at 
6
th
 postnatal day. 
Pearson 
correlation 
between 
depression 
symptoms at 7-8
th
 
day postnatal and 
plasma free Trp 
levels was -0.60 
(P < 0.01). 
1 
Abou-Saleh et 
al., 1999, United 
Arab Emirates 
Cross-
sectional, 
n = 62, 
30.8 ± 
6.2 yr 
8% scored ≥ 
11 in Arabic 
version of the 
EPDS at 7
th
 
postnatal day. 
In plasma, Met = 
31.46 ± 15.40, 
Trp = 40.77 ± 
12.48, Tyr = 
72.28 ± 29.89, 
Phe = 65.18 ± 
16.17 (m/L), 
and vitamin B12= 
374.94 ± 152.2 
(pg/mL) at 7
th
 
postnatal day. 
Pearson 
correlations 
between the 
EPDS scores at 
7
th
 day postnatal 
and the levels of 
plasma 
biomarkers were: 
-0.44 (P <0.001) 
for Met, -0.44 (P 
<0.01) for Trp, -
0.41 (P <0.01) for 
Tyr, 0.39 (P 
<0.01) for 
vitamin B12, 0.35 
(P <0.01) for 
Phe/Tyr, -0.27 (P 
<0.05) for Tyr/ 
(Val, Leu, Ile, 
Phe). 
5 
Maes et al., 
Cross-
sectional, 
(NR %) 
diagnosed by 
In plasma, mean 
± SE at third 
Pearson 
correlation 
5 
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1992, Belgium n = 29, 
mean ± 
SE = 
28.3 ± 
0.7 yr 
Zung 
Depression 
and Anxiety 
scale, BDI, 
and the STAI 
at third 
postnatal day. 
postnatal day: 
Trp = 51.2 ± 1.8, 
Val = 193.6 ± 
5.0, Leu = 142.1 
± 4.4, Ile = 67.7 
± 2.4 and Phe = 
100.7 ± 4.0 (10
-6
 
mol/L).  
between plasma 
Trp/ (Val, Leu, 
Ile, Phe) and the 
Zung Depression, 
Zung Anxiety and 
STAI scores at 
third postnatal 
day were -0.46 (P 
= 0.007), -0.51 (P 
= 0.003) and -
0.53 (P = 0.002), 
respectively. 
Outcomes in pregnancy and 
postpartum 
   
Chong et al., 
2014, Singapore 
16
 
Cohort, 
n = 967, 
30.7 ± 
5.1 yr 
7.2% scored 
in the EPDS ≥ 
15 at 26
th
-28
th
 
gw and 10.4% 
scored ≥ 13 at 
third postnatal 
mo. 
In plasma, folate 
= 40.4 (36.4) in 
EPDS < 15 and 
27.3 ± 13.8 
(nmol/L) in 
EPDS ≥ 15; 
vitamin B12 = 
220.1 ± 77.6 in 
EPDS < 15 and 
211.2 ± 66.0 
(pmol/L) in 
EPDS ≥ 15 at 
26
th
-28
th
 gw. 
ORs (95% CI) of 
depression in 
antenatal period 
were 0.69 (0.52-
0.94) and 1.07 
(0.79-1.45) for 1 
SD increase in 
log-transformed 
plasma folate and 
vitamin B12 
levels, 
respectively. For 
postnatal period, 
ORs (95% CI) of 
depression were 
0.75 (0.58-0.99) 
and 1.08 (0.83-
1.40) for 1 SD 
increase in log-
transformed 
folate and vitamin 
B12 levels, 
respectively. All 
analysis were 
adjusted for 
maternal age, 
ethnicity, 
educational level 
of the mother, 
gravidity, smoke 
exposure before 
and during 
pregnancy, 
alcohol 
consumption 
before pregnancy, 
variables 
associated with 
health status of 
mothers and 
children. Results 
of postnatal 
depression were 
further adjusted 
9 
62 
 
by previous 
depressive 
symptoms. 
Maes et al., 
2001, Belgium 
Cohort, 
n = 98, 
27.8 ± 
3.5 yr 
21 women 
scored at the
 
q75 values of 
changes in the 
STAI score 
from the 3
rd
-
6
th
 day before 
the delivery, 
first postnatal 
day, to third 
postnatal day. 
Plasma Phe = 
86.1 ± 16.8 at 3
rd
-
6
th
 day before the 
delivery, 101.9 ± 
24.9 at first 
postnatal day and 
110.0 ± 22.9 
(mol/L) and 
third postnatal 
day. 
Pearson 
correlation 
between the 
changes of STAI 
score and changes 
in plasma Phe 
levels was 0.16 (P 
= 0.04) from 3
rd
-
6
th
 day before the 
delivery to first 
and third 
postnatal day. 
 
FERRITIN       
Outcomes in postpartum    
Albacar et al., 
2011, Spain 
17, 18
 
Cohort, 
n = 729, 
31.7 ± 
4.7 yr 
9% scored > 9 
on the 
Spanish 
version of 
EPDS at 8
th
-
32
th
 postnatal 
wk. 
Serum ferritin = 
21.3 ± 13.5 
(µg/L) at 48 
postnatal h. 
OR (95% CI) of 
depression scored 
> 9 on EPDS at 8-
32
th
 postnatal wk 
was 3.73 (1.84-
7.56) in women in 
the category of 
serum ferritin < 
7.26 µg/L vs 
higher levels. 
Results were 
adjusted for 
employment 
status, c-reactive 
protein and 
transferrin 
saturation. 
6 
Armony-Sivan et 
al., 2012, China
 
19
 
Cohort, 
n = 567, 
24.6 ± 
3.7 yr 
 24.5% at 24–
48 h after 
delivery and 
20.3% at 6
th
 
postnatal wk 
scored ≥ 10 in 
the Chinese 
version of 
EPDS.  
Serum ferritin = 
41.9 ± 35.3 at 
13
th
-20
th
 and 14.1 
± 13.8 (ng/mL) at 
36
th
 gw. 
Spearman 
correlations 
between serum 
ferritin in mid- or 
late pregnancy 
and EPDS scores 
after delivery or 
at 6
th 
postnatal wk 
were < 0.10 (P > 
0.05). 
6 
ZINC     
 
Outcomes in pregnancy and 
postpartum 
  
 
Roomruangwong 
et al., 2016, 
Thailand 
Cohort, 
n = 72, no 
depression 
group = 
HDRS, 
EPDS, BDI, 
and STAI at 
third trimester 
Serum Zn no 
depression = 80.3 ± 
14.7 and in 
depression =71.3 ± 
OR (95% CI) of 
prenatal 
depression as 
scored ≥ 11 on 
5 
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29.6 ± 
7.1; 
depression 
group = 
27.5 ± 
6.3 yr 
and 4
th
-6
th
 
postnatal wk. 
Scores ≥ 11 
on EPDS was 
considered as 
prenatal 
depression 
(NR %). 
8.3 (g/dL) at 
third trimester. 
EPDS was 4.16 
(1.42-12.22) for a 
1-unit increase of 
the inverse of 
serum zinc levels. 
Results were 
adjusted for age, 
lifetime history of 
depression, 
premenstrual 
syndrome and 
anxiety disorders. 
Pearson 
correlations 
between serum 
zinc levels and 
scores were -
0.425 (P < 0.001) 
for EPDS,-0.478 
(P < 0.001) for 
HDRS, -0.507 (P 
< 0.001) for BDI 
and -0.042 (P = 
0.729) for STAI. 
Wojcik et al., 
2006, Poland 
Cohort, 
n = 66, 
31.0 ± 
1.0 yr 
42% and 29% 
scored in 9 ≥ 
self-rated 
EPDS at third 
and 30
th
 
postnatal day, 
respectively. 
Serum Zn, mean 
(SE) (mg/L) = 
0.61 ± 0.01 at 
third postnatal 
day and 0.80 ± 
0.02 at 30
th
 
postnatal day. 
Spearman 
correlation 
between EPDRS 
scores and serum 
Zn levels was -
0.2968 (P = 
0.014) at third 
and 30
th
 postnatal 
day. 
6 
Abbreviations: BDI = Beck Depression Inventory; CESD = Center for Epidemiologic Studies 
Depression Scale; CI = confidence interval; DASS = Depression, Anxiety and Stress Scales; EPDS = 
Edinburgh Postnatal Depression Scale; gw = gestational week; Hcy = homocysteine; HDRS = 
Hamilton Depression Rating scale; h = hour; Ile = isoleucine; IR = interquartile range; Leu = leucine; 
log = logarithm; MAACL = Multiple Affect Adjective Check List; MADRS = Montgomery-Asberg 
Depression Rating Scale; Met = methionine; mo = month; NOS = Newcastle-Ottawa scale; NR = not 
reported; Phe = Phenylalanine; PHQ = Patient Health Questionnaire; SD =Standard deviation; SE = 
Standard Error; STAI = Spielberger’s State-Trait Anxiety Index; Trp = tryptophan; Tyr = tyrosine; 
Val = valine; VAS = Visual Analogue scale; wk = week; yr = years; Zn = zinc.  
1
 23% of women had vitamin D deficiency (< 29 nM) and 21% had insufficiency (30-50 nM). 
2
 These studies are based on data from the same primary research. Only African-American ethnicity 
women were selected to participate in the study. 
3
 The study visits occurred between February 2009 and June 2010. 
4
 Women had prenatal vitamin prescriptions (74% used 50,000 IU/ week after assessment and other 
women took in the prenatal period 400 IU of vitamin D).
  
5 
43.3%
 
were deficient (< 12 ng/mL), 31.7% inadequate (12-20 ng/mL) and 18.3% sufficient (20-30 
ng/mL) in levels of vitamin D.  
6 
40% of women were insufficient/ deficient (< 32 ng/mL) and 4.2% deficient (< 20 ng/mL) in vitamin 
D levels. 
7 
85% of
 
women had inadequacy/ deficiency (< 20 ng/mL) in vitamin D levels. 
8 
82.6% of women were deficient (< 20 ng/mL) in vitamin D levels. Participants were of Chinese 
family origin 
9
 Study data were collected between June 2012 and October 2012. 
64 
 
10 
7.6% of women used vitamin D supplement of 1,200 IU/ day at least 3 days weekly, 84.6% of 400 
IU/ day and 7.6% never used.
  
11 
11% of women had severe vitamin D deficiency (< 10 ng/mL) and 40.3% mild deficiency (10-20 
ng/mL). 
12
 Participants were of Caucasian ethnicity. 
13
 Around 20% of women took vitamin supplements.
 
14
 96.1% and 56.4 of women took acid folic and vitamin B supplements at 11 weeks. 
15 
1.44% and 0.32% of the women had marginal folate status (< 350 nmol/L) at baseline and 
pregnancy, respectively. 
16
 Participants were Singaporean citizens or permanent residents of Chinese, Malay or Indian ethnicity 
with parents of homogenous ethnicity background. 93.1% and 93.0% of women took folic and 
vitamin B12 supplements, respectively. 
17
 The study was conducted between December 2003 and October 2004. 
18 
Participants were of Caucasian ethnicity (only Spanish origin). 13.9% of women had marginal iron 
deficiency (ferritin < 12 µg/L and transferrin < 16%) and 24.7% suffered depletion of iron stores 
(ferritin < 12 µg/L).  
19
 30% of anemic women were iron deficient (soluble transferrin receptor/log ferritin index > 14) in 
middle pregnancy (n = 74 anemics) and 93% in late pregnancy (n = 141 anemics). 
 
Table 4. Summary of the associations between the nutritional biomarkers and depression in 
women during pregnancy and the first postpartum year reported in at least two included 
studies.  
Nutritional biomarker Total of studies (reference) 
1
 
Number of studies with any 
significant association 
(reference) 
2
 
Depression in pregnancy    
AA 2 (Pinto et al., 2016,46, Vaz et al., 2014 56) 1 (Vaz et al., 2014) 
Ada 2 (Pinto et al., 2016, Vaz et al., 2014) 1 (Vaz et al., 2014) 
ALA 3 (Pinto et al., 2016, Rees et al., 2009, Vaz 
et al., 2014) 
0 
DHA 5 (Pinto et al., 2016, Rees et al., 2009, Sallis 
et al., 2014, Shiraishi et al., 2015, Vaz et al., 
2014) 
3 (Pinto et al., 2016, Rees et 
al., 2009, Shiraishi et al., 
2015) 
DPA (-3) 3 (Pinto et al., 2016, Rees et al., 2009, Vaz 
et al., 2014) 
1 (Pinto et al., 2016) 
EPA 5 (Pinto et al., 2016, Rees et al., 2009, Sallis 
et al., 2014, Shiraishi et al., 2015, Vaz et al., 
2014) 
1 (Pinto et al., 2016) 
LA 2 (Pinto et al., 2016,46, Vaz et al., 2014) 0 
total ω-6 PUFA 4 (Chong et al., 2015, Mattes et al., 2009, 
Pinto et al., 2016, Rees et al., 2009) 
0 
total ω-3 PUFA 4 (Chong et al., 2015, Mattes et al., 2009, 
Pinto et al., 2016, Rees et al., 2009) 
2 (Pinto et al., 2016, Rees et 
al., 2009) 
ω-6-PUFA/ω-3-PUFA 4 (Chong et al., 2015, Mattes et al., 2009, 
Pinto et al., 2016, Rees et al., 2009) 
1 (Pinto et al., 2016) 
AA/EPA 2 (Chong et al., 2015, Rees et al., 2009) 0 
HDL-Cholesterol 2 (Teofilo et al., 2014, Troisi et al., 2002) 1 (Teofilo et al., 2014) 
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Vitamin D  3 (Brandenbarg et al., 2012, Cassidy-
Bushrow et al., 2012, Huang et al., 2014) 
2 (Brandenbarg et al., 2012, 
Cassidy-Bushrow et al., 
2012) 
Folate 2 (Chong et al., 2014, Watanabe et al., 2011) 1 (Chong et al., 2014) 
Depression in postpartum    
AA 2 (Markhus et al., 2013, Parker et al., 2015) 0 
DHA 4 (Markhus et al., 2013, Otto et al., 2003, 
Parker et al., 2015, Sallis et al., 2014) 
1 (Markhus et al., 2013) 
DPA (-3) 3 (Markhus et al., 2013 , Otto et al., 2003,  
Parker et al., 2015) 
1 (Markhus et al., 2013) 
EPA 3 (Markhus et al., 2013, Parker et al., 2015, 
Sallis et al., 2014) 
1 (Parker et al., 2015) 
total ω-6 PUFA 2 (Chong et al., 2015, Parker et al., 2015) 1 (Parker et al., 2015) 
total ω-3 PUFA 2 (Chong et al., 2015, Parker et al., 2015) 1 (Parker et al., 2015) 
ω-6-PUFA/ω-3-PUFA 2 (Chong et al., 2015, Parker et al., 2015) 0 
Total SFA 2 (Markhus et al., 2013, Parker et al., 2015) 0 
Cholesterol  4 (Grussu et al., 2007, Ploeckinger et al., 
1996, Troisi et al., 2002, van Dam et al., 
1999) 
3 (Grussu et al., 2007, 
Ploeckinger et al., 1996, 
Troisi et al., 2002) 
Vitamin D 4 (Accortt et al., 2016 , Fu et al., 2015, Gur 
et al., 2014, Robinson et al., 2014) 
3 (Fu et al., 2015, Gur et al., 
2014, Robinson et al., 2014) 
Folate 2 (Blunden et al., 2012, Chong et al., 2014) 1 (Chong et al., 2014) 
Vitamin B12 2 (Abou-Saleh et al., 1999, Chong et al., 
2014) 
1 (Abou-Saleh et al., 1999) 
Tryptophan 5
3
 (Abou-Saleh et al., 1999, Handley et al., 
1977, Handley et al., 1980, Maes et al., 
1992, Stein et al., 1976) 
4
3
 (Abou-Saleh et al., 1999, 
Handley et al., 1977, Maes et 
al., 1992, Stein et al., 1976) 
Ferritin 2 (Albacar et al., 2011, Armony-Sivan et al., 
2012) 
1 (Albacar et al., 2011) 
Abbreviations: AA = arachidonic acid; AdA = adrenic acid; ALA = α-linolenic acid; DHA = 
docosahexaenoic acid; DPA = docosapentaenoic acid; EPA = eicosapentaenoic acid; LA = linoleic 
acid; PUFA = polyunsaturated fatty acids; SFA = saturated fatty acids.  
1 
Number total of studies evaluating the association between the same nutritional biomarker and 
depression in pregnancy and in the postpartum period reported in at least two included studies. 
2
 Number of studies that found any type of significant association (ORs, correlations and regression 
coefficients) between the same nutritional biomarker and depression. 
3
 Maes et al., 1992 reported the Pearson correlation between tryptophan/ (valine, leucine, isoleucine, 
phenylalanine) and the Zung Depression, Zung Anxiety and State Anxiety Inventory scores at third 
postnatal day. This ratio between amino acids reflects the availability of tryptophan to the brain. 
 
Table 5. Possible future directions emerged from this systematic review 
 More studies are needed on nutritional biomarkers and anxiety and psychological 
stress. 
 A single standard tool to assess depression during pregnancy and postpartum. 
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 More well-designed studies are needed (with adequate statistical power and 
reporting complete epidemiological association measures, evaluating the same time 
periods, and reporting data on ethnicity and others important confounder factors). 
 Fatty acids levels should be presented in absolute concentrations to allow the 
comparison between studies. 
 Nutritional supplementation should be considered in the study design/data analysis 
of the studies. 
 Longitudinal studies diagnosing psychological distress in more than one point 
should present number of women and how they were managed in the follow-up. 
 More longitudinal studies are needed to evaluate trace elements, amino acids, 
vitamins, lipids and psychological distress measured over pregnancy and postpartum. 
 Women’ nutritional status should be reported for micronutrients in studies. 
 
Highlights 
 Thirty-eight studies were reviewed for associations.  
 Serum vitamin D showed an inverse association with pre/postnatal depression. 
  Fatty acids and depression and anxiety had divergent or no associations. 
 Results are limited by the higher variability across the studies.  
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